| E_01_001 | -- | chr6:86160197~86176777 | Melanoma | Melanoma | ChIP-seq,ChIP-qPCR |
| E_01_002 | ERαenh588 | chr11:69329684~69330954 | MCF-7,T-47D | Breast Cancer | ChIP-seq,CRISPR/Cas9,Luciferase Reporter Assay,Western blot,Competitive Proliferation Assay |
| E_01_003 | NEC1 Enhancer | chr2:223164458~223164688 | Melanoma | Melanoma | Phylogenetic Footprinting,Luciferase Reporter Assay |
| E_01_004 | NEC2 Enhancer | chr2:223164846~223165065 | Melanoma | Melanoma | Phylogenetic Footprinting,Luciferase Reporter Assay |
| E_01_005 | p53enh3507 | chr6:36631690~36640853 | BJ | -- | ChIP-seq,CRISPR/Cas9,Luciferase Reporter Assay,siRNA,GRO-seq |
| E_01_006 | p53enh3508 | chr6:36640690~36643070 | BJ | -- | ChIP-seq,CRISPR/Cas9,Luciferase Reporter Assay,siRNA |
| E_01_007 | -- | chr21:36180372~36181392 | Leukemia Cell Lines,K-562 | Acute Myeloid Leukemia | Luciferase Reporter Assay,DNaseI hypersensitivity |
| E_01_008 | -- | chr8:23448386~23454886 | Human CD34+ Hematopoietic Stem/Progenitor Cell | -- | CRISPR/Cas9,ChIP-seq |
| E_01_009 | -- | chr8:23433011~23439511 | Human CD34+ Hematopoietic Stem/Progenitor Cell | -- | CRISPR/Cas9,ChIP-seq |
| E_01_010 | -- | chr8:23422136~23432636 | Human CD34+ Hematopoietic Stem/Progenitor Cell | -- | CRISPR/Cas9,ChIP-seq |
| E_01_011 | MYC-LASE | chr8:129166547~129190290 | A549,NCI-H358,NCI-H2009 | Lung Adenocarcinoma | ChIP-seq,Luciferase Reporter Assay,3C-qPCR,CRISPR/Cas9,siRNA |
| E_01_012 | -- | chr5:51773619~51857504 | HEK-293,β-Cell | Type 2 Diabetes Mellitus | RNA-seq,ChIP-seq,ChIP,EMSA,PCR,4C,Luciferase Reporter Assay |
| E_01_013 | -- | chr13:73880690~73990596 | BICR-31 | Esophageal Carcinoma | ChIP-seq,Luciferase Reporter Assay,3C-qPCR,CRISPR/Cas9,siRNA |
| E_01_014 | -- | chr6:170855462~170856787 | HEK-293,β-Cell | Type 2 Diabetes Mellitus | RNA-seq,ChIP-seq,ChIP,EMSA,PCR,4C,Luciferase Reporter Assay |
| E_01_015 | -- | chr13:73880413~74042621 | Esophageal Carcinoma | Lung Adenocarcinoma | ChIP-seq,Luciferase Reporter Assay,3C-qPCR,CRISPR/Cas9,siRNA |
| E_01_016 | -- | chr13:27523026~27544353 | Colon Crypt Cell | Colorectal Carcinoma | ChIP-seq,Luciferase Reporter Assay,3C-qPCR,CRISPR/Cas9,siRNA |
| E_01_017 | -- | chr20:48997377~49019434 | Hep G2 | Hepatocellular Carcinoma | ChIP-seq,Luciferase Reporter Assay,3C-qPCR,CRISPR/Cas9,siRNA |
| E_01_018 | -- | chr7:117038917~117040917 | Caco-2 | -- | RT-qPCR,4C,ChIP,CRISPR/Cas9 |
| E_01_019 | -- | chr7:117099048~117099450 | Caco-2 | -- | RT-qPCR,4C,ChIP,CRISPR/Cas9 |
| E_01_020 | -- | chr7:117228051~117229440 | Caco-2 | -- | RT-qPCR,4C,ChIP,CRISPR/Cas9 |
| E_01_021 | MYC-ECSE (MYC endometrial carcinoma super-Enhancer) | chr8:129543949~129554294 | Endometrial Carcinoma Cell Lines Ishikawa | Endometrial Carcinoma | ChIP-seq,Luciferase Reporter Assay,3C-qPCR,CRISPR/Cas9,siRNA |
| E_01_022 | -- | chr8:98253530~98257713 | Mantle Cell Lymphoma (MCL) | Small B Cell Lymphoma | ChIP-seq,ChIP-qPCR,4C-seq |
| E_01_023 | -- | chr8:98310330~98314427 | Mantle Cell Lymphoma (MCL) | Small B Cell Lymphoma | ChIP-seq,ChIP-qPCR,4C-seq |
| E_01_024 | -- | chr17:26077792~26078792 | A549 | -- | 3C |
| E_01_025 | CD200 distal Enhancer | chr3:112045517~112046117 | HUVEC | Graft Rejection,Autoimmune Diseases,Spontaneous Abortion | Luciferase Reporter Assay,ChIP,PCR,DNase I Hypersensitivity Assay |
| E_01_026 | -- | chr6:37772587~37778315 | HEK-293,β-cell | Type 2 Diabetes Mellitus | RNA-seq,ChIP-seq,ChIP,EMSA,PCR,4C,Luciferase Reporter Assay |
| E_01_027 | hRLD2 Enhancer | chr13:43111372~43112072 | MG-63 | Osteopetrosis | EMSA,ChIP,RT-PCR |
| E_01_028 | -- | chr17:26072592~26074592 | Hep G2 | -- | Luciferase Reporter Assay,PCR,EMSA,ChIP |
| E_01_029 | HREs Enhancer | chr3:48598405~48598558 | TE-671 | Myocardial Ischemia | Luciferase Reporter Assay,RT-PCR |
| E_01_030 | SF-1 Enhancer | chrx:30317939~30318739 | HEK-293 | X-Linked Congenital Adrenal Hypoplasia | Luciferase Reporter Assay,PCR |
| E_01_031 | MnSOD Enhancer | chr6:160101620~160102231 | PC-3 | -- | RT-PCR,Luciferase Reporter Assay,EMSA,ChIP |
| E_01_032 | MnSOD Enhancer | chr6:160101890~160102231 | PC-3 | -- | Luciferase Reporter Assay,EMSA,PCR,ChIP |
| E_01_033 | Di | chr16:67519201~67519833 | H295R,N38 | -- | Transgenic mice,Luciferase Reporter Assay |
| E_01_034 | Dic | chr16:67519609~67519833 | H295R,N38 | -- | Transgenic mice,Luciferase Reporter Assay |
| E_01_035 | Diii | chr16:67520417~67521049 | H295R,N38 | -- | Transgenic mice,Luciferase Reporter Assay |
| E_01_036 | Diiia | chr16:67520417~67520638 | AtT-20,N38 | -- | Transgenic mice,Luciferase Reporter Assay,Transfection |
| E_01_037 | Diiib | chr16:67520620~67520851 | H295R | -- | Luciferase Reporter Assay,Transfection |
| E_01_038 | FKBP51 Enhancer | chr6:35574362~35576362 | A549 | -- | RT-qPCR,ChIP |
| E_01_039 | FKBP51 Enhancer | chr6:35505138~35511492 | A549,VCaP | -- | RT-qPCR,ChIP |
| E_01_040 | FKBP51 Enhancer | chr6:35616283~35622638 | A549,VCaP | -- | RT-qPCR,ChIP |
| E_01_041 | FKBP51 Enhancer | chr6:35636622~35642872 | A549,VCaP | -- | RT-qPCR,ChIP |
| E_01_042 | RET Enhancer | chr10:43569296~43572684 | SK-N-BE | -- | Luciferase Reporter Assay,PCR |
| E_01_043 | CCL2 Enhancer | chr17:32579684~32579693 | HEK-293,HEK-MOR Cells | -- | ChIP,PCR |
| E_01_044 | androgen Enhancer | chr19:50850114~50850982 | LNCaP | Prostate Cancer | Luciferase Reporter Assay,RT-PCR |
| E_01_045 | -- | chr1:23881789~23881796 | Immortalized Murine Gonadotrope LβT2 Cell,Ovarian Cancer Cell | -- | qRT-PCR,Luciferase Reporter Assay,ChIP |
| E_01_046 | -- | chr22:24236392~24237411 | CEMC7A,THP-1,293T,SW982 | Rheumatoid Arthritis | Luciferase Reporter Assay,PCR,EMSA,DNaseI-seq |
| E_01_047 | -- | chr18:60786011~60788011 | JURKAT | -- | 3C,ChIP,RT-PCR |
| E_01_048 | LCT Enhancer | chr2:136531405~136531505 | Caco-2 | -- | Transfection,Luciferase Reporter Assay |
| E_01_049 | -- | chr12:100693355~100695355 | MCF-7 | -- | ChIP,Western blot,siRNA,qPCR |
| E_01_050 | -- | chr12:100731355~100733355 | MCF-7 | -- | ChIP,Western blot,siRNA,qPCR |
| E_01_051 | -- | chr10:131265598~131265656 | Human Bronchial Epithelial Cell,Lung cancer-derived Cell Lines,Glioblastoma Cell Lines | Lung Adenocarcinoma | Luciferase Reporter Assay,PCR |
| E_01_052 | WT1 Enhancer | chr11:32403489~32405489 | Human Podocyte Cell Line AB8/13 | -- | qRT-PCR,Luciferase Reporter Assay |
| E_01_053 | -- | chr6:135459326~135461326 | K-562 | -- | Luciferase Reporter Assay,PCR,ChIP |
| E_01_054 | -- | chr12:8217947~8219702 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_055 | -- | chr12:54757502~54758950 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_056 | -- | chr17:34411749~34415000 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_057 | -- | chr17:34416207~34419359 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_058 | -- | chr17:34429460~34432613 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_059 | -- | chr2:113595983~113598617 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_060 | -- | chr2:113597789~113600339 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_061 | -- | chr5:158755252~158761634 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_062 | -- | chr5:158783552~158790360 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_063 | -- | chr5:158787331~158794352 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_064 | -- | chr1:203273730~203275395 | HeLa,THP-1 | -- | ChIP-qPCR,ChIP |
| E_01_065 | -- | chr1:226065482~226067482 | Perinodal Cells | -- | PCR,Transgenic mice,Immunostaining |
| E_01_066 | -- | chr1:204123719~204123725 | Calu-6 | -- | Luciferase Reporter Assay,PCR |
| E_01_067 | -- | chr21:35982223~35983306 | Acute T-Cell Leukaemia Cell | -- | Luciferase Reporter Assay,PCR |
| E_01_068 | -- | chr21:36141738~36142821 | Acute T-Cell Leukaemia Cell | -- | Luciferase Reporter Assay,PCR |
| E_01_069 | -- | chr2:136582836~136583741 | Caco-2,Cheek Cell | -- | Luciferase Reporter Assay,PCR,EMSA |
| E_01_070 | -- | chr1:101402363~101412724 | HUVEC | Atherosclerosis | Luciferase Reporter Assay,PCR,ChIP,ChIP-qPCR,ChIP-seq |
| E_01_071 | -- | chr1:64083756~64083861 | SK-N-MC | Insomnia | ChIP,PCR |
| E_01_072 | -- | chr1:64087305~64087660 | SK-N-MC | Insomnia | ChIP,PCR |
| E_01_073 | -- | chr20:8684437~8686556 | SK-N-MC | Insomnia | ChIP,PCR |
| E_01_074 | -- | chr20:8687417~8688741 | SK-N-MC | Insomnia | ChIP,PCR |
| E_01_075 | -- | chr20:8718344~8719933 | SK-N-MC | Insomnia | ChIP,PCR |
| E_01_076 | -- | chr1:33353796~33354196 | HC11 Mammary Epithelium | -- | Luciferase Reporter Assay,PCR,ChIP |
| E_01_077 | -- | chr8:128747315~128748315 | HCT 116 | Colorectal Cancer | ChIP,PCR,ChIP-seq |
| E_01_078 | -- | chr8:128749415~128750415 | HCT 116 | Colorectal Cancer | ChIP,PCR,ChIP-seq |
| E_01_079 | -- | chr8:128346390~128347994 | HEK-293 | -- | ChIP,PCR,ChIP-seq |
| E_01_080 | -- | chr8:128327941~128330615 | HEK-293 | -- | ChIP,PCR,ChIP-seq |
| E_01_081 | -- | chr8:128299198~128301336 | HEK-293 | -- | ChIP,PCR,ChIP-seq |
| E_01_082 | -- | chr8:128296257~128297326 | HEK-293 | -- | ChIP,PCR,ChIP-seq |
| E_01_083 | -- | chr21:39823183~39825183 | T-acute lymphoblastic leukemia (T-ALL),Molt4,REH,416B | T-Cell Acute Lymphoblastic Leukemia | Luciferase Reporter Assay,PCR,ChIP,ChIP-PCR,ChIP-seq |
| E_01_084 | -- | chr17:32565596~32566796 | U-87MG | -- | Luciferase Reporter Assay,PCR,ChIP,EMSA,3C |
| E_01_085 | UBE2C Enhancer | chr20:44430820~44433428 | LNCaP,PC-3 | Prostate Cancer | RT-PCR,Luciferase Reporter Assay,ChIP,3C |
| E_01_086 | UBE2C Enhancer | chr20:44441255~44444472 | LNCaP,PC-3 | Prostate Cancer | RT-PCR,Luciferase Reporter Assay,ChIP,3C |
| E_01_087 | UBE2C Enhancer | chr20:44478646~44484559 | LNCaP,PC-3 | Prostate Cancer | RT-PCR,Luciferase Reporter Assay,ChIP,3C |
| E_01_088 | UBE2C Enhancer | chr20:44413081~44426646 | PC-3,DU-145 | Prostate Cancer | RT-PCR,Luciferase Reporter Assay,ChIP,3C |
| E_01_089 | -- | chr20:62593247~62595247 | SK-N-AS,Hep G2 | Amyotrophic Lateral Sclerosis | Luciferase Reporter Assay,EMSA,PCR |
| E_01_090 | GATA Enhancer | chr4:101576220~101578659 | Endothelial Cells (ECs) | -- | ChIP-seq,ChIP-qPCR |
| E_01_091 | NAGS Enhancer | chr17:42078932~42079032 | Ureagenesis | -- | Luciferase Reporter Assay |
| E_01_092 | -- | chr12:7940709~7941994 | HEK-293 | -- | Luciferase Reporter Assay |
| E_01_093 | -- | chr17:62028378~62028924 | HEK-293,HeLa | -- | Luciferase Reporter Assay |
| E_01_094 | -- | chr8:117978845~117979466 | βTC-3,αTC-6 | Type 2 Diabetes Mellitus | Luciferase Reporter Assay,PCR,Transfection |
| E_01_095 | -- | chr5:134350424~134352424 | MCF-7 | -- | ChIP,Luciferase Reporter Assay,3C |
| E_01_096 | -- | chr6:31130679~31130761 | NT2 | -- | ChIP,qPCR |
| E_01_097 | -- | chr6:31130445~31130606 | NT2 | -- | ChIP,qPCR |
| E_01_098 | -- | chr6:31129568~31129735 | NT2 | -- | ChIP,qPCR |
| E_01_099 | PSA Enhancer | chr19:51354804~51355203 | LNCaP | -- | qRT-PCR,ChIP |
| E_01_100 | TMPRSS2 Enhancer | chr21:42822120~42822800 | LNCaP | -- | qRT-PCR,ChIP |
| E_01_101 | -- | chr20:55417234~55417304 | NK-92,U-2 OS | -- | Luciferase Reporter Assay,EMSA,RT-PCR,ChIP |
| E_01_102 | -- | chr9:132491985~132492534 | HFL-1 | Lung Cancer | DNaseI-seq,ChIP,RT-PCR |
| E_01_103 | -- | chr14:90847327~90849327 | MCF-7,K-562,HeLa,HCT 116,Nb4 | Congenital Limb Deformity | 3C-qPCR,Luciferase Reporter Assay,ChIP-seq |
| E_01_104 | -- | chr5:44385749~44386845 | Human Embryos | -- | ChIP,EMSA |
| E_01_105 | -- | chr11:101981958~101982137 | HCT 116,SW620,SW480,RKO | Colorectal Cancer | ChIP,RT-PCR,Luciferase Reporter Assay |
| E_01_106 | ARE Enhancer | chr22:35766960~35768960 | HeLa | Breast Cancer | qPCR,ChIP |
| E_01_107 | -- | chr17:42078865~42079198 | Hep G2 | -- | PCR,ChIP,Luciferase Reporter Assay |
| E_01_108 | -- | chr9:136141944~136147321 | K-562,KATO III | -- | Luciferase Reporter Assay,PCR |
| E_01_109 | -- | chr12:8036824~8048824 | HEK-293,HeLa | -- | ChIP-PCR,RT-PCR,3C-ChIP,ChIP-seq |
| E_01_110 | -- | chr12:8035824~8037824 | HEK-293,HeLa | -- | ChIP-PCR,RT-PCR,3C-ChIP,ChIP-seq |
| E_01_111 | -- | chr17:69107686~69108045 | LNCaP | -- | Luciferase Reporter Assay,ChIP,3C-qPCR,ChIP-qPCR |
| E_01_112 | -- | chr17:69108466~69108765 | LNCaP | -- | Luciferase Reporter Assay,ChIP,3C-qPCR,ChIP-qPCR |
| E_01_113 | -- | chr8:124323890~124325890 | LNCaP | Prostate Cancer | qPCR,Luciferase Reporter Assay,ChIP,EMSA,3C |
| E_01_114 | -- | chr8:124321890~124323890 | LNCaP | Prostate Cancer | qPCR,Luciferase Reporter Assay,ChIP,EMSA,3C |
| E_01_115 | -- | chr8:124319890~124321890 | LNCaP | Prostate Cancer | qPCR,Luciferase Reporter Assay,ChIP,EMSA,3C |
| E_01_116 | bone Enhancer | chr17:48258757~48260757 | C2C12 | -- | Luciferase Reporter Assay |
| E_01_117 | | chr1:24601612~24626812 | Raji lymphoblastic B cells | Breast Cancer | ChIP-seq,Western blot |
| E_01_118 | -- | chr15:90288698~90290698 | Embryonic Stem Cell | -- | ChIP-seq,qRT-PCR,Luciferase Reporter Assay |
| E_01_119 | P53BER4 Enhancer | chr1:181104024~181104549 | MCF-7 | -- | qRT-PCR,4C,ChIP-seq,Luciferase Reporter Assay,ChIP |
| E_01_120 | P53BER2 Enhancer | chr9 :118706130~118707280 | MCF-7 | -- | qRT-PCR,4C,ChIP-seq,Luciferase Reporter Assay,ChIP |
| E_01_121 | -- | chr11:8301851~8303851 | T-acute lymphoblastic leukemia (T-ALL) | T-Cell leukemia | ChIP,RT-PCR,Luciferase Reporter Assay |
| E_01_122 | -- | chr9:21816751~21818751 | Human 2BS Diploid Fibroblast Cells | -- | ChIP-qPCR,3C,ChIP,Luciferase Reporter Assay,EMSA |
| E_01_123 | -- | chr2:191834162~191834795 | Mm96 | -- | Luciferase Reporter Assay,ChIP,PCR |
| E_01_124 | -- | chr12:48369059~48369213 | SW 1353 | -- | PCR,ChIP,Luciferase Reporter Assay |
| E_01_125 | -- | chr11:72897942~72912333 | MCF-7 | -- | 3C,ChIP-seq,ChIP-qPCR |
| E_01_126 | -- | chr5:172648612~172649177 | Leukocytes | Congenital Heart Disease | PCR,Luciferase Reporter Assay |
| E_01_127 | -- | chr12:21439733~21439973 | HeLa | -- | DNaseI-seq,PCR |
| E_01_128 | -- | chr12:68549287~68549545 | HeLa | -- | DNaseI-seq,PCR |
| E_01_129 | -- | chr12:68549796~68550055 | HeLa | -- | DNaseI-seq,PCR |
| E_01_130 | -- | chr12:68553503~68553754 | HeLa | -- | DNaseI-seq,PCR |
| E_01_131 | -- | chr12:68553762~68554012 | HeLa | -- | DNaseI-seq,PCR |
| E_01_132 | -- | chr21:43770915~43772915 | MCF-7 | -- | RT-PCR,ChIP |
| E_01_133 | AP3 Enhancer | chr6:161119825~161121825 | Hep G2,MCF-7 | Hypoplasminogenemia | Luciferase Reporter Assay,ChIP,EMSA,PCR |
| E_01_134 | ERE Enhancer | chr6:161110725~161112725 | Hep G2,MCF-7 | Hypoplasminogenemia | Luciferase Reporter Assay,ChIP,EMSA,PCR |
| E_01_135 | -- | chr12:48368959~48369159 | HeLa,HEK-293 | -- | PCR,ChIP |
| E_01_136 | PSA Enhancer | chr8:57069398~57069482 | LNCaP | -- | ChIP,qPCR,qRT-PCR |
| E_01_137 | ECR18 Enhancer | chr19:57566145~57571006 | HeLa,HEK-293 | -- | Luciferase Reporter Assay,PCR,3C,ChIP |
| E_01_138 | -- | chr1:1083900~1085900 | HMLE | -- | qRT-PCR,Luciferase Reporter Assay,ChIP-seq,ChIP-qPCR |
| E_01_139 | -- | chr10:23502416~23510031 | Embryonic Stem Cell | Pancreatic Agenesis | ChIP,PCR,3C,EMSA |
| E_01_140 | -- | chr11:111150916~111155431 | HCT 116,SW480,Colorectal Cancer | Colorectal Cancer | PCR,ChIP-seq,Luciferase Reporter Assay,Transfection,EMSA |
| E_01_141 | -- | chr8:127047315~127049315 | Acute Myeloid Leukemia Cell | Acute Leukemia | ChIP,ChIP-seq,Luciferase Reporter Assay,4C,ChIP-qPCR,3C,qPCR |
| E_01_142 | -- | chr21:43781591~43782591 | MCF-7,MDA-MB-231,293T | Mixed-Lineage Leukemia 1 | qRT-PCR,ChIP |
| E_01_143 | -- | chr21:43772291~43774291 | MCF-7,MDA-MB-231,293T | Mixed-Lineage Leukemia 1 | qRT-PCR,ChIP |
| E_01_144 | -- | chr21:43771491~43773491 | MCF-7,MDA-MB-231,293T | Mixed-Lineage Leukemia 1 | qRT-PCR,ChIP |
| E_01_145 | -- | chr17:72860066~72860183 | HeLa,H295R,KGN | -- | ChIP,Luciferase Reporter Assay,PCR,EMSA |
| E_01_146 | -- | chr11:110716521~110832306 | B-Cell Lymphoma Cell Lines | Diffuse Large B-Cell Lymphoma | ChIP-seq,ChIP-qPCR |
| E_01_147 | -- | chr3:188892648~189232665 | B-Cell Lymphoma Cell Lines | Diffuse Large B-Cell Lymphoma | ChIP-seq,ChIP-qPCR |
| E_01_148 | -- | chr1:226085596~226087967 | Embryonic Stem Cell | -- | ChIP-seq,siRNA |
| E_01_149 | -- | chr14:77264349~77265491 | HEK-293 | Alzheimer's Disease | ChIP-seq,Luciferase Reporter Assay,PCR |
| E_01_150 | -- | chr15:37116298~37122452 | Embryonic Stem Cell | -- | ChIP-qPCR,ChIP-seq,ChIP |
| E_01_151 | -- | chr13:95865319~95866199 | Umbilical Vein Endothelial Cell,ESCC | Esophageal Squamous Cell Carcinoma | Luciferase Reporter Assay |
| E_01_152 | -- | chr8:128709135~128745673 | AN3 CA,RL95-2,HEC-1-B | Endometrial Cancer | ChIP,ChIP-PCR,ChIP-seq,qRT-PCR |
| E_01_153 | -- | chr8:128392788~128433173 | AN3 CA,RL95-2,HEC-1-B | Endometrial Cancer | ChIP,ChIP-PCR,ChIP-seq,qRT-PCR |
| E_01_154 | -- | chr4:74586223~74591223 | AC16 | Heart Disease | RT-qPCR,ChIP-seq |
| E_01_155 | -- | chr8:128230172~128243000 | HCT 116,RKO | Colorectal Cancer | qRT-PCR,3C |
| E_01_156 | -- | chr8:119677099~119681977 | HT-29,HCT 116 | Colorectal Cancer | qRT-PCR,3C,ChIP |
| E_01_157 | -- | chr8:141161900~141175436 | Lymphoblastoid Cell Lines | Intellectual Disability | RT-PCR,ChIP,Luciferase Reporter Assay,3C,DNaseI-seq |
| E_01_158 | -- | chr17:60983452~60984775 | HEK293FT,FLP-IN T-REX 293 CELLS | Colorectal Cancer | qRT-PCR,ChIP,Luciferase Reporter Assay |
| E_01_159 | -- | chr17:60986269~60989232 | HEK293FT,FLP-IN T-REX 293 CELLS | Colorectal Cancer | qRT-PCR,ChIP,Luciferase Reporter Assay |
| E_01_160 | -- | chr8:128816178~128817335 | HEK293FT,FLP-IN T-REX 293 CELLS | Colorectal Cancer | qRT-PCR,ChIP,Luciferase Reporter Assay |
| E_01_161 | -- | chr5:139970046~139972237 | Peripheral Blood Monocytes | -- | RT-PCR,ChIP,Luciferase Reporter Assay,ChIP-seq |
| E_01_162 | -- | chr5:139974521~139975981 | Peripheral Blood Monocytes | -- | RT-PCR,ChIP,Luciferase Reporter Assay,ChIP-seq |
| E_01_163 | -- | chr5:139985479~139987671 | Peripheral Blood Monocytes | -- | RT-PCR,ChIP,Luciferase Reporter Assay,ChIP-seq |
| E_01_164 | -- | chr5:139987854~139989680 | Peripheral Blood Monocytes | -- | RT-PCR,ChIP,Luciferase Reporter Assay,ChIP-seq |
| E_01_165 | -- | chr5:139990822~139992831 | Peripheral Blood Monocytes | -- | RT-PCR,ChIP,Luciferase Reporter Assay,ChIP-seq |
| E_01_166 | -- | chr5:140009726~140011735 | Peripheral Blood Monocytes | -- | RT-PCR,ChIP,Luciferase Reporter Assay,ChIP-seq |
| E_01_167 | -- | chr1:9996966~9997243 | GM12878,CD4+ T Cell | -- | Hi-C,4C,Luciferase Reporter Assay,ChIP-seq |
| E_01_168 | -- | chr3:11249688~11250280 | GM12878,CD4+ T Cell | -- | Hi-C,4C,Luciferase Reporter Assay,ChIP-seq |
| E_01_169 | -- | chr3:184276287~184278287 | Crc Cell,HT-29 | -- | Luciferase Reporter Assay,ChIP,qRT-PCR |
| E_01_170 | -- | chr19:51358995~51369041 | LNCaP,VCaP | Prostate Cancer | Luciferase Reporter Assay,RT-PCR,ChIP,3C |
| E_01_171 | -- | chr12:54357811~54358445 | KYSE-30,KESY-150,ESCC | Esophageal Squamous Cell Carcinoma | Luciferase Reporter Assay,PCR |
| E_01_172 | -- | chr6:36632237~36634237 | Human Diploid BJ Fibroblast Cell Lines | -- | ChIP-qPCR,ChIP,ChIP-seq |
| E_01_173 | -- | chr8:143896217~143898217 | Human Diploid BJ Fibroblast Cell Lines | -- | ChIP-qPCR,ChIP,ChIP-seq |
| E_01_174 | -- | chr16:86212040~86271919 | Lung | -- | ChIP-seq,qRT-PCR,ChIP-qPCR |
| E_01_175 | -- | chr9:124638991~124641160 | LP89 | -- | ChIP-seq,ChIP-qPCR |
| E_01_176 | -- | chr3:32993199~32996133 | T Cell | Asthma | ChIP-seq,PCR |
| E_01_177 | -- | chr3:33000399~33003599 | T Cell | Asthma | ChIP-seq,PCR |
| E_01_178 | -- | chr3:34181595~34184395 | T Cell | Asthma | ChIP-seq,PCR |
| E_01_179 | -- | chr3:34201595~34204662 | T Cell | Asthma | ChIP-seq,PCR |
| E_01_180 | -- | chr12:48368875~48369590 | 10T1/2,MC615 Cells,MCF-7 | Osteoarthritis | RT-PCR,ChIP,Luciferase Reporter Assay,EMSA |
| E_01_181 | -- | chr8:130179643~130181490 | HPB-ALL,JURKAT,T-acute lymphoblastic leukemia (T-ALL) | T-Cell Acute Lymphoblastic Leukemia | ChIP-seq,ChIP,Luciferase Reporter Assay,3C,PCR |
| E_01_182 | -- | chr10:6064657~6065397 | T Cell | Autoimmune Diseases | EMSA,Luciferase Reporter Assay |
| E_01_183 | -- | chr2:217918268~217921910 | Breast Cancer Cell | Breast Cancer | Luciferase Reporter Assay,ChIP-seq,3C,PCR |
| E_01_184 | DHS-44 Enhancer | chr7:117075514~117075933 | Human Bronchial Epithelial Cell | -- | Luciferase Reporter Assay,EMSA,RT-PCR,ChIP |
| E_01_185 | -- | chr19:2482923~2484923 | HEK-293 | -- | ChIP,qRT-PCR,3C |
| E_01_186 | -- | chr10:43568986~43571244 | Neural Crest Cells | Hirschsprung Disease | RT-PCR,Luciferase Reporter Assay |
| E_01_187 | -- | chr10:43571244~43572713 | Neural Crest Cells | Hirschsprung Disease | RT-PCR,Luciferase Reporter Assay |
| E_01_188 | -- | chr7:94002773~94005073 | Fibroblasts | Systemic Sclerosis | Luciferase Reporter Assay |
| E_01_189 | -- | chr22:42411333~42413643 | Human Primary Hepatocytes | -- | 4C,ChIP |
| E_01_190 | -- | chr22:42411544~42415106 | Human Primary Hepatocytes | -- | 4C,ChIP |
| E_01_191 | -- | chr22:42411769~42414470 | Human Primary Hepatocytes | -- | 4C,ChIP |
| E_01_192 | -- | chr1:98509888~98511451 | Neuroblastoma Cell Lines | Schizophrenia | Luciferase Reporter Assay |
| E_01_193 | -- | chr1:98514701~98515055 | Neuroblastoma Cell Lines | Schizophrenia | Luciferase Reporter Assay,3C,PCR,EMSA |
| E_01_194 | -- | chr1:98516486~98522430 | Neuroblastoma Cell Lines | Schizophrenia | Luciferase Reporter Assay,3C,PCR,EMSA |
| E_01_195 | -- | chr1:98517055~98517909 | Neuroblastoma Cell Lines | Schizophrenia | Luciferase Reporter Assay,3C,PCR,EMSA |
| E_01_196 | -- | chr12:98559923~98563615 | Induced Pluripotent Stem Cells | Schizophrenia | 3C,Luciferase Reporter Assay |
| E_01_197 | -- | chr12:98562692~98566384 | Induced Pluripotent Stem Cells | Schizophrenia | 3C |
| E_01_198 | -- | chr14:97410723~97443618 | HeLa,293T | Ewing Sarcoma | shRNA,RNA-seq,qRT-PCR,3C,Immunohistochemistry |
| E_01_199 | -- | chr1:23881244~23881761 | Human Monocytes/Macrophages | Cardiometabolic Disorders | Luciferase Reporter Assay |
| E_01_200 | -- | chr1:23888938~23889083 | Human Monocytes/Macrophages | Cardiometabolic Disorders | Luciferase Reporter Assay |
| E_01_201 | MMP9 Enhancer | chr20:44637014~44637468 | Hepatocellular Carcinoma | Hepatocellular Carcinoma | Luciferase Reporter Assay |
| E_01_202 | -- | chr17:69487560~69491400 | HEK-293 | Disorders Of Sexual Development | Luciferase Reporter Assay,Transgenic mice |
| E_01_203 | hCNS1 Enhancer | chr17:61927353~61928827 | GC-spd(ts),Hepa 1-6,293T | -- | PCR,Luciferase Reporter Assay |
| E_01_204 | -- | chr17:6285838~6586838 | Human Liver Cell | Steatosis | Luciferase Reporter Assay,EMSA,ChIP |
| E_01_205 | -- | chr17:6565038~6567038 | Human Liver Cell | Fatty Liver Disease | Luciferase Reporter Assay,EMSA,ChIP |
| E_01_206 | -- | chr5:125345378~125345495 | HIT DH5A cells (RBC) | Adult-onset Autosomal Dominant Demyelinating Leukodystrophy | Luciferase Reporter Assay,4C,PCR |
| E_01_207 | -- | chr5:125995862~125995972 | HIT DH5A cells (RBC) | Adult-onset Autosomal Dominant Demyelinating Leukodystrophy | Luciferase Reporter Assay,4C,PCR |
| E_01_208 | | chr10:123099588~123100426 | GMSM-K (human embry-onic oral epithelial cells) | Cleft Palate | Luciferase Reporter Assay,PCR |
| E_01_209 | | chr17:54754755~54758235 | GMSM-K (human embry-onic oral epithelial cells) | Cleft Palate | Luciferase Reporter Assay,PCR |
| E_01_210 | | chr17:54775600~54778000 | GMSM-K (human embry-onic oral epithelial cells) | Cleft Palate | Luciferase Reporter Assay,PCR |
| E_01_211 | ENH3 Enhancer | chr6:45410618~45417584 | B-CPAP,TPC1 | -- | Luciferase Reporter Assay,RT-PCR,ChIP |
| E_01_212 | -- | chr7:155845627~155847652 | Caco-2 | -- | Luciferase Reporter Assay |
| E_01_213 | CXCR5 Enhancer | chr11:118767466~118769582 | MCF-7 | -- | Luciferase Reporter Assay,PCR |
| E_01_214 | PRE3 Enhancer | chr8:81286250~81293977 | Lymphoblastoid Cell Lines | National Institute of Allergy and Infectious Diseases | ChIP-seq,Luciferase Reporter Assay,PCR,3C |
| E_01_215 | PROX1-11 Enhancer | chr1:214150511~214151337 | K-562 | Lymphedema | ChIP-seq,Luciferase Reporter Assay |
| E_01_216 | -- | chr10:64737032~64737909 | Mouse Embryonic Stem Cell | Ewing Sarcoma | ChIP-seq,Luciferase Reporter Assay |
| E_01_217 | EBAs Enhancer | chr2:98362566~98364423 | HEK-293 | -- | ChIP-seq,Hi-C,Luciferase Reporter Assay |
| E_01_218 | -- | chr3:186938165~186940165 | Lymphoma Cell | B-Cell Lymphoma | ChIP-seq,3C,qRT-PCR |
| E_01_219 | -- | chr3:187088165~187909165 | Lymphoma Cell | B-Cell Lymphoma | ChIP-seq,3C,qRT-PCR |
| E_01_220 | -- | chr3:187559165~187589165 | Lymphoma Cell | B-Cell Lymphoma | ChIP-seq,3C,qRT-PCR |
| E_01_221 | -- | chr20:42977441~42978040 | Hep G2 | Hepatocellular Carcinoma | Luciferase Reporter Assay |
| E_01_222 | -- | chr4:56895793~56962351 | Human Embryonic Kidney Cell | -- | ChIP-seq,5' RACE |
| E_01_223 | -- | chr7:114541370~114542201 | HEK-293,SK-N-MC | -- | Luciferase Reporter Assay |
| E_01_224 | -- | chr6:1614188~1617051 | Embryonic Stem Cell | -- | Enhancer Assay |
| E_01_225 | -- | chr6:1615843~1617834 | Embryonic Stem Cell | -- | Enhancer Assay |
| E_01_226 | -- | chr6:1619348~1621343 | Embryonic Stem Cell | -- | Enhancer Assay |
| E_01_227 | -- | chr6:1701730~1704441 | Embryonic Stem Cell | -- | Enhancer Assay |
| E_01_228 | -- | chr12:56728500~56735000 | THP-1 | Mycobacterium Tuberculosis | ChIP-seq,ChIP |
| E_01_229 | -- | chr6:30904342~30904788 | Embryonic Stem Cell | -- | CRISPR/Cas9,Luciferase Reporter Assay,4C-seq |
| E_01_230 | CARDIAC Enhancer | chr5:148785000~148815000 | Cardiac Progenitor Cell | -- | ChIP-seq,Immunohistochemistry,Luciferase Reporter Assay,RIP |
| E_01_231 | -- | chr22:35686840~35687280 | Vascular Endothelial Cell | -- | ChIP,RT-PCR,qPCR |
| E_01_232 | HS2 enhancer | chr11:5301600~5302400 | K-562 | -- | CRISPR/Cas9,qRT-PCR |
| E_01_233 | -- | chr11:8271697~8279492 | Neuroblastoma Cell Lines | Neuroblastoma | ChIP-seq,Luciferase Reporter Assay |
| E_01_234 | -- | chr4:26075179~26135897 | CD4+ T Cell | Rheumatoid Arthritis | ChIP-seq,PCR,ELISA,qPCR |
| E_01_235 | -- | chr11:118540532~118575295 | Normal Human Astrocyte | Glioma | Luciferase Reporter Assay,3C |
| E_01_236 | -- | chr7:117011495~117063767 | Human Nasal Epithelial Cell,Skin Fibroblasts Cell | Cystic Fibrosis | Hi-C,5C,Luciferase Reporter Assay,PCR |
| E_01_237 | -- | chr7:117282955~117335227 | Human Nasal Epithelial Cell,Skin Fibroblasts Cell | Epithelial Cancer | Hi-C,5C,Luciferase Reporter Assay,PCR |
| E_01_238 | MYC Super-Enhancer | chr8:130386715~130591515 | Acute Myeloid Leukemia Cell | -- | ChIP,ChIP-qPCR |
| E_01_239 | -- | chr1:181117806~181122451 | HCT 116 | Cervical Cancer | ChIP-seq,Luciferase Reporter Assay,4C-seq |
| E_01_240 | -- | chr6:31139599~31139921 | Embryonic Stem Cell | -- | CRISPR/Cas9,Luciferase Reporter Assay |
| E_01_241 | -- | chr6:30646843~30647217 | Embryonic Stem Cell | -- | CRISPR/Cas9,Luciferase Reporter Assay,4C-seq |
| E_01_242 | -- | chr18:60786011~60788011 | Human T Lymphoid Cell | -- | 3C,ChIP,RT-PCR |
| E_01_243 | -- | chr6:31126537~31126685 | Embryonic Stem Cell | -- | CRISPR/Cas9,Luciferase Reporter Assay,4C-seq |
| E_01_244 | ACP10 Enhancer | chr8:128412386~128415392 | LNCaP,C4-2B | Prostate Cancer | 4C-seq |
| E_01_245 | -- | chr13:40839693~40853195 | CD4+ T Cell | -- | ChIP-seq,Luciferase Reporter Assay |
| E_01_246 | -- | chr9:4600913~4608373 | CD4+ T Cell | -- | ChIP-seq,Luciferase Reporter Assay |
| E_01_247 | C11ORF82 Enhancer | chr11:82608774~82612886 | IMR-90 | -- | 3C-qPCR,Hi-C |
| E_01_248 | -- | chr20:54937784~54938182 | G1E-ER4 Cells | -- | ChIP-seq,ChIP,Luciferase Reporter Assay |
| E_01_249 | LAMC2 Enhancer | chr1:183149939~183150336 | Intestinal Epithelial Cell | -- | Luciferase Reporter Assay |
| E_01_250 | NgR13' Enhancer | chr22:20224442~20228467 | NT2/D1 | -- | Luciferase Reporter Assay,PCR |
| E_01_251 | NGB Enhancer | chr14:77635927~77639784 | SH-SY5Y | Alzheimer's Disease | 3C,Luciferase Reporter Assay,ChIP,CRISPR/Cas9 |
| E_01_252 | IGF2 Enhancer | chr11:2219531~2239062 | HCC-15 | Lung Cancer | ChIP-seq,Luciferase Reporter Assay |
| E_01_253 | P2RY2 Enhancer | chr11:72905735~72906735 | MCF-7 | -- | smFISH,ChIP,3C |
| E_01_254 | FOXC1 Enhancer | chr6:1636681~1642781 | MCF-7 | -- | smFISH,ChIP |
| E_01_255 | | ch3:189109942~189219942 | Mammary Epithelial Cell MCF10A and MCF12A | Breast Cancer | qPCR,ChIP |
| E_01_256 | | ch3:189203942~189313942 | Mammary Epithelial Cell MCF10A and MCF12A | Breast Cancer | qPCR,ChIP |
| E_01_257 | | ch1:24589812~24645812 | Mammary Epithelial Cell MCF10A and MCF12A | Breast Cancer | qPCR,ChIP |
| E_01_258 | SR4 Enhancer | chr17:69541883~69542989 | TM4 | Disorders Of Sexual Development | Luciferase Reporter Assay,PCR,Transgenic mice,Immunofluorescence |
| E_01_259 | GIMAP Enhancer | chr7:150360500~150366500 | T-acute lymphoblastic leukemia (T-ALL) | T-Cell Acute Lymphoblastic Leukemia | ChIP-seq,CRISPR/Cas9,PCR |
| E_01_260 | NBEAL2 Enhancer | chr3:46988575~46990242 | K-562 | -- | Luciferase Reporter Assay,ChIP,RT-PCR |
| E_01_261 | YY1 Enhancer | chr12:109986000~109986710 | WT Mouse Embryonic Fibroblasts | -- | ChIP-seq,ChIP-seq,RT-qPCR |
| E_01_262 | -- | chrX:55054584~55054678 | K-562 | -- | 3C,Luciferase Reporter Assay,RT-qPCR,CRISPR/Cas9 |
| E_01_263 | -- | chrX:55041578~55041679 | K-562 | -- | 3C,Luciferase Reporter Assay,RT-qPCR,CRISPR/Cas9 |
| E_01_264 | -- | chr1:92921568~92937818 | HEL | Leukemia | ChIP-seq,ChIP-qPCR |
| E_01_265 | pCREB Enhancer | chr3:181572712~181574712 | MCF-7 | -- | ChIP,qPCR |
| E_01_266 | LMO1 Enhancer | chr11:8240851~8242851 | T-acute lymphoblastic leukemia (T-ALL),RPMI-8402 and Jurkat | -- | ChIP-seq,Luciferase Reporter Assay,ChIA-PET |
| E_01_267 | FBP1 Enhancer | chr9:97396388~97401553 | Hepatocellular Carcinoma | Hepatocellular carcinoma | ChIP-seq,ChIP,RT-PCR |
| E_01_268 | -- | chr4:174441057~174442400 | Neuroblastoma Cell Lines | Neuroblastoma | ChIP-seq,Western blot |
| E_01_269 | CD47 SE E5 | chr3:107702615~107714185 | MCF-7 | Breast Cancer | ChIP-seq,Luciferase Reporter Assay |
| E_01_270 | CD47 SE E3.2 | chr3:107842838~107845592 | MCF-7 | Breast Cancer | ChIP-seq,Luciferase Reporter Assay |
| E_01_271 | CD47 SE E7 | chr3:107846969~107854683 | MCF-7 | Breast Cancer | ChIP-seq,Luciferase Reporter Assay |
| E_01_272 | -- | chr11:17666830~17677080 | Human Fibroblast Cell Lines | Alveolar Rhabdomyosarcoma | ChIP-seq,4C,Luciferase Reporter Assay |
| E_01_273 | -- | chr11:355447~358949 | A549,HEK-293 | -- | Luciferase Reporter Assay,CRISPR/Cas9,ChIP,EMSA,3C |
| E_01_274 | -- | chr1:221049243~221051243 | HUVEC | -- | ChIP-seq,Luciferase Reporter Assay,ChIP |
| E_01_275 | -- | chr18:61533339~61545796 | MonoMac6,K-562 | -- | ChIP-seq,Luciferase Reporter Assay,qRT-PCR |
| E_01_276 | -- | Chr11:45846943~45846959 | U-2 OS | -- | Luciferase Reporter Assay |
| E_01_277 | SIX6 Enhancer | chr14:60973427~60975430 | Eye | Primary Open-Angle Glaucoma | Transgenic zebrafish,Luciferase Reporter Assay |
| E_01_278 | -- | chr3:181432912~181433312 | Lung Adenocarcinoma | Lung Cancer | Luciferase Reporter Assay,ChIP-qPCR |
| E_01_279 | -- | chr7:129854050~129895632 | Adipose Progenitor Cell | -- | ChIP-seq,FISH |
| E_01_280 | -- | chr6:12490000~12590000 | HUVEC | Coronary Artery Disease,Migraine Headache,Cervical Artery Dissection,Fibromuscular Dysplasia,Hypertension | 4C-seq,Luciferase Reporter Assay |
| E_01_281 | -- | chr4:77511788~77605824 | LNCaP,CWR22Rv1 | Prostate Cancer | ChIP-seq,Dual-Luciferase Reporter Assay,ChIP,PCR |
| E_01_282 | -- | chr4:94419116~94437803 | 231/ERαWt Cells,231/ERαLQ Cells | Breast Cancer | 3C-qPCR,ChIP-seq,ChIP-qPCR |
| E_01_283 | DGKA Enhancer | chr12:56330413~56330909 | A9 | Fibrotic Disease | ChIP-seq,PCR,ChIP |
| E_01_284 | rs6758183
enhancer | chr2:226998914~227004586 | Human Corneal Epithelial Cells | -- | Luciferase Reporter Assay,ChIP-seq |
| E_01_285 | | chr6:31092587~31094587 | Human Corneal Epithelial Cells | -- | Luciferase Reporter Assay,ChIP-seq |
| E_01_286 | -- | chr8:27455903~27456103 | HEK-293 | Alzheimer's Disease | Luciferase Reporter Assay,CRISPR/Cas9,EMSA,ChIP |
| E_01_287 | PGC-1α super-Enhancer | chr4:23811733~23994829 | CHL-1 | Melanoma | ChIP-seq |
| E_01_288 | HGE(HER2 gene body Enhancer ) | chr17:37879571~37880263 | K-562 | Breast Cancer | DNaseI-seq,ChIP-PCR,ChIP,Luciferase Reporter Assay |
| E_01_289 | -- | chr3:180728712~180730712 | Neural Stem Cells | Low-grade astrocytomas | ChIP-seq,ChIP-qPCR,4C-seq,Hi-C |
| E_01_290 | BACH2 Enhancer | chr6:91004796~91006944 | B Cell | -- | RT-PCR,ChIP-qPCR,Luciferase Reporter Assay |
| E_01_291 | -- | chr7:94002773~94005073 | Lung Myofibroblast | -- | Luciferase Reporter Assay,ChIP |
| E_01_292 | -- | chr12:47471429~47487762 | SKmel147 | -- | ATAC-seq,ChIP-seq,Luciferase Reporter Assay,Transfection,CRISPR/Cas9 |
| E_01_293 | -- | chr19:34845032~34847032 | Prostate Cancer Cell Lines | -- | WHG-STARR-seq,ChIP-seq,Luciferase Reporter Assay,ATAC-seq,RNA-seq |
| E_01_294 | -- | chr13:28545205~28547205 | Colorectal Cancer | -- | ChIP-seq,ChIP,EMSA,Luciferase Reporter Assay |
| E_01_295 | -- | chr16:68777928~68779928 | Colorectal Cancer | -- | ChIP-seq,ChIP,EMSA,Luciferase Reporter Assay |
| E_01_296 | -- | chr3:184276287~184278287 | Colorectal Cancer | -- | ChIP-seq,ChIP,EMSA,Luciferase Reporter Assay |
| E_01_297 | -- | chr4:55859107~55860311 | Kasumi-1,U937-AE | -- | PCR,Luciferase Reporter Assay,ChIP-qPCR,ChIP-3C |
| E_01_298 | -- | chr10:63525013~63527013 | T-acute lymphoblastic leukemia (T-ALL) | T-Cell Acute Lymphoblastic Leukemia | ChIA-PET,CRISPR/Cas9 |
| E_01_299 | LEENE Enhancer | chr14:56245000~56285000 | Endothelial Cells (ECs) | -- | ChIP-seq,qPCR,Hi-C |
| E_01_300 | -- | chr2:11633299~11641134 | MCF-7 | Breast Cancer | ChIP-seq,3C,ChIP-qPCR |
| E_01_301 | -- | chr2:8818311~8820522 | Neuroblastoma Cell Lines | Neuroblastoma | ChIP-seq,Western blot |
| E_01_302 | -- | chr4:174435828~174438057 | Neuroblastoma Cell Lines | Neuroblastoma | ChIP-seq,Western blot |
| E_01_303 | -- | chr3:107662655~107762655 | MCF-7 | Breast Cancer | ChIP-seq,Luciferase Reporter Assay,ChIA-PET |
| E_01_304 | -- | chrx:106959618~106962917 | U-2 OS | -- | ChIP-qPCR,4C |
| E_01_305 | -- | chr3:69863244~70187654 | Melanoma | Melanoma | ChIP-seq,Western blot,siRNA,qPCR |
| E_01_306 | -- | chr14:99770698~99782638 | A673/TR/shEF1 Cells | Ewing Sarcoma | Luciferase Reporter Assay,qRT-PCR |
| E_01_307 | -- | chr1:116896120~116904325 | A673/TR/shEF1 Cells | Ewing Sarcoma | Luciferase Reporter Assay,qRT-PCR |
| E_01_308 | -- | chr16:74568579~74583481 | A673/TR/shEF1 Cells | Ewing Sarcoma | Luciferase Reporter Assay,qRT-PCR |
| E_01_309 | -- | chr6:138226720~138233280 | B Cell,Monocytes | Autoimmune Diseases | CRISPR/Cas9,Hi-C,ChIP-seq |
| E_01_310 | -- | chr7:45920458~45923258 | Hep G2 | -- | FAIRE-qPCR,Luciferase Reporter Assay |
| E_01_311 | -- | chr15:66074477~66098025 | Erythroleukemia Cell,B lymphoblastoid Cell | -- | Hi-C,ChIP-seq |
| E_01_312 | -- | chr17:31209116~31240452 | Erythroleukemia Cell,B lymphoblastoid Cell | -- | Hi-C,ChIP-seq,CRISPR/Cas9 |
| E_01_313 | HPSE eRNA | chr4:84277627~84281723 | AGS | Gastric Cancer | 3C,ChIP-seq,qPCR |
| E_01_314 | -- | chr3:150450617~150456921 | MCF-7 | Breast Cancer | ChIP-seq,ChIP-qPCR |
| E_01_315 | -- | chr6:1679010~1683521 | MCF-7 | Breast Cancer | ChIP-seq,ChIP-qPCR |
| E_01_316 | -- | chr8:128206162~128314310 | HCT 116 | -- | 4C,ChIP-seq |
| E_01_317 | -- | chr8:129046628~129096067 | K-562 | -- | 4C,ChIP-seq |
| E_01_318 | -- | chr8:130569971~130616320 | K-562 | -- | 4C,ChIP-seq |
| E_01_319 | -- | chr8:130693569~130739918 | K-562 | -- | 4C,ChIP-seq |
| E_01_320 | OCT4 Intronic Enhancer | chr6:31137269~31137697 | Embryonic Stem Cell | -- | ATAC-seq,Luciferase Reporter Assay,ChIP-seq |
| E_01_321 | AHRR Enhancer | chr5:372500~376000 | Circulating Monocytes Cell | Cardiovascular Cancer | ChIP-seq,RNA-seq |
| E_01_322 | ERG Super-Enhancer | chr21:40003867~40015913 | HEL | Leukemia | ChIP-qPCR,ChIP-seq |
| E_01_323 | MLH1 Enhancer | chr3:36999364~37001216 | SW620,RKO | Lynch Syndrome | ChIP-qPCR,3C,Luciferase Reporter Assay,CRISPR/Cas9 |
| E_01_324 | COUP-TFII Enhancer | chr15:96725740~96737960 | E11.5 Heart | Congenital Heart Disease | ChIP-seq,Hi-C |
| E_01_325 | -- | chr12:132285987~132290767 | Ishikawa Cell | -- | ChIP-seq |
| E_01_326 | -- | chr12:132281970~132287430 | Ishikawa Cell | -- | ChIP-seq |
| E_01_327 | -- | chr12:132342570~132347690 | Ishikawa Cell | -- | ChIP-seq |
| E_01_328 | -- | chr1:160536893~160537651 | HL-60,293T | -- | ChIP-seq,ChIP-qPCR |
| E_01_329 | -- | chr1:160542651~160543257 | HL-60,293T | -- | ChIP-seq,ChIP-qPCR |
| E_01_330 | -- | chr5:149457542~149458807 | HL-60,293T | -- | ChIP-seq,ChIP-qPCR |
| E_01_331 | HBG-4kb HS site | chr11:5279732~5280272 | K-562 | Erythrocytic Leukemia | ChIP-seq |
| E_01_332 | -- | chr8:38291071~38304326 | Embryonic Stem Cell | -- | ChIP-STARR-seq |
| E_01_333 | -- | chr16:86422446~86426834 | HEK-293 | -- | ChIP-seq,Luciferase Reporter Assay,CRISPR/Cas9 |
| E_01_334 | -- | chr20:30244800~30316534 | MDA-MB-231 | Breast Cancer | ChIP-qPCR,ChIP-seq,Luciferase Reporter Assay |
| E_01_335 | -- | chr6:37997692~38001538 | T-47D | Breast Cancer | ChIP-qPCR,ChIP-seq,Luciferase Reporter Assay |
| E_01_336 | -- | chr6:38010769~38019538 | T-47D | Breast Cancer | ChIP-qPCR,ChIP-seq,Luciferase Reporter Assay |
| E_01_337 | -- | chr6:38032307~38035230 | T-47D | Breast Cancer | ChIP-qPCR,ChIP-seq,Luciferase Reporter Assay |
| E_01_338 | -- | chr6:151917241~152028736 | T-47D | Breast Cancer | ChIP-qPCR,ChIP-seq,Luciferase Reporter Assay |
| E_01_339 | gtPBREM Enhancer | chr2:234665349~234665739 | Hep G2 | Hepatocellular Carcinoma | Luciferase Reporter Assay,qRT-PCR |
| E_01_340 | -- | chr14:76419740~76421740 | LNCaP | Prostate Cancer | ChIP-seq,ChIP-qPCR |
| E_01_341 | -- | chr1:47704791~47705107 | T-acute lymphoblastic leukemia (T-ALL) | Central Nervous System Leukemia | ChIP-qPCR,qRT-PCR,ChIP,Transgenic mice |
| E_01_342 | -- | chr19:15308673~15308842 | T-acute lymphoblastic leukemia (T-ALL) | Central Nervous System Leukemia | ChIP-qPCR,qRT-PCR,ChIP,Transgenic mice |
| E_01_343 | -- | chr10:33492690~33519530 | Normal Epidermal Cell | EEC syndrome | siRNA,ChIP-seq |
| E_01_344 | -- | chr10:33512793~33539633 | Normal Epidermal Cell | EEC syndrome | siRNA,ChIP-seq |
| E_01_345 | -- | chr10:33637535~33664375 | Normal Epidermal Cell | EEC syndrome | siRNA,ChIP-seq |
| E_01_346 | -- | chr14:106327635~106328903 | GM12878 | -- | Luciferase Reporter Assay,ChIP-seq |
| E_01_347 | -- | chr9:126900000~126900625 | GM12878 | -- | Luciferase Reporter Assay,ChIP-seq |
| E_01_348 | -- | chr9:126964375~126965000 | GM12878 | -- | Luciferase Reporter Assay,ChIP-seq |
| E_01_349 | -- | chr9:126980625~126981125 | GM12878 | -- | Luciferase Reporter Assay,ChIP-seq |
| E_01_350 | -- | chr9:127001250~127001875 | GM12878 | -- | Luciferase Reporter Assay,ChIP-seq |
| E_01_351 | -- | chr9:127047500~127048375 | GM12878 | -- | Luciferase Reporter Assay,ChIP-seq |
| E_01_352 | POU5F1 proximal Enhancer | chr6:31139519~31140167 | Human Primordial Germ Cell | -- | ATAC-seq,ChIP-seq |
| E_01_353 | POU5F1 naive Enhancer | chr6:31137056~31138028 | Human Primordial Germ Cell | -- | ATAC-seq,ChIP-seq |
| E_01_354 | POU5F1 distal Enhancer | chr6:31140556~31141204 | Human Primordial Germ Cell | -- | ATAC-seq,ChIP-seq,ChIP-qPCR |
| E_01_355 | IgH 3' Enhancer | chr14:105051517~105351516 | DHL-4,DHL-9 | Lymphoma | 3C,PCR,ChIP |
| E_01_356 | FKBP51 Enhancer | chr6:35628362~35641362 | A549 | -- | ChIP,Transgenic mice |
| E_01_357 | RET Enhancer | chr10:43569045~43569456 | SK-N-BE | -- | ChIP |
| E_01_358 | -- | chr12:114463712~114464080 | HeLa,293T | Congenital Heart Disease | EMSA,PCR,ChIP-seq |
| E_01_359 | -- | chr12:114701207~114704691 | HeLa,293T | Congenital Heart Disease | EMSA,PCR,ChIP-seq |
| E_01_360 | -- | chr12:114853271~114858238 | HeLa,293T | Congenital Heart Disease | EMSA,PCR,ChIP-seq |
| E_01_361 | -- | chr11:69468761~69470761 | MDA-MB-23,MDA-MB-436 | -- | 3C,ChIP,qPCR |
| E_01_362 | -- | chr11:69468873~69470873 | MCF-7 | Breast Tumor | ChIP,PCR,3C |
| E_01_363 | -- | chr7:116374406~116376406 | COLO 829 | Melanoma | 3C,ChIP |
| E_01_364 | -- | chr11:47363009~47364009 | Human Myeloid Cells | Acute Myeloid Leukemia | ChIP |
| E_01_365 | -- | chr20:21452815~21462458 | HeLa,293T | Ewing Sarcoma | ChIP-seq,PCR,3C |
| E_01_366 | -- | chr21:42668000~42671000 | Breast Cancer Cell | -- | ChIP-seq,ChIP,GRO-seq |
| E_01_367 | -- | chr22:35736840~35737280 | Endothelial Cells (ECs) | -- | ChIP,PCR |
| E_01_368 | -- | chr9:14538685~14540685 | MCF-7 | Adenoid Cystic Carcinoma | Luciferase Reporter Assay,RT-PCR,ChIP,ChIP-seq |
| E_01_369 | -- | chr9:14923979~14925979 | MCF-7 | Adenoid Cystic Carcinoma | Luciferase Reporter Assay,RT-PCR,ChIP,ChIP-seq |
| E_01_370 | -- | chr9:15066136~15068136 | MCF-7 | Adenoid Cystic Carcinoma | Luciferase Reporter Assay,RT-PCR,ChIP,ChIP-seq |
| E_01_371 | -- | chr1:92170642~92172642 | MCF-7 | Adenoid Cystic Carcinoma | Luciferase Reporter Assay,RT-PCR,ChIP,ChIP-seq |
| E_01_372 | -- | chr1:92254801~92256801 | MCF-7 | Adenoid Cystic Carcinoma | Luciferase Reporter Assay,RT-PCR,ChIP,ChIP-seq |
| E_01_373 | -- | chr1:92331533~92333533 | MCF-7 | Adenoid Cystic Carcinoma | Luciferase Reporter Assay,RT-PCR,ChIP,ChIP-seq |
| E_01_374 | -- | chr1:92359751~92361751 | MCF-7 | Adenoid Cystic Carcinoma | Luciferase Reporter Assay,RT-PCR,ChIP,ChIP-seq |
| E_01_375 | -- | chr1:92392919~92394919 | MCF-7 | Adenoid Cystic Carcinoma | Luciferase Reporter Assay,RT-PCR,ChIP,ChIP-seq |
| E_01_376 | -- | chr1:92567177~92569177 | MCF-7 | Adenoid Cystic Carcinoma | Luciferase Reporter Assay,RT-PCR,ChIP,ChIP-seq |
| E_01_377 | ES-specific enhancers (ESSEs) | chr6:43891400~43898360 | K-562 | -- | ChIP-seq |
| E_01_378 | PRE | chr1:67739940~67741075 | Lymphoblastoid Cell Lines | Ankylosing Spondylitis | DNase I Hypersensitivity Assay |
| E_01_379 | | chr5:110175800~110176600 | 293T | Heart Failure | Luciferase Reporter Assay |
| E_01_380 | -- | chr3:108015219~108015290 | 293T | -- | Luciferase Reporter Assay,Transient Transfection Assay,RNA-seq,PCR |
| E_01_381 | -- | chr11:109985003~109985222 | Osteosarcoma Stem Cells | Osteosarcoma | ChIP-PCR,Luciferase Reporter Assay |
| E_01_382 | BY707159.1 Enhancer | chr7:150700000~150705000 | Endothelial Cells (ECs) | -- | ChIP-seq,qPCR,4C-seq,Hi-C |
| E_01_383 | | chr6:36640937~36642937 | MCF-7,A549,HeLa,293T | Tumour | ChIP,qPCR |
| E_01_384 | | chr6:36647237~36649237 | MCF-7,A549,HeLa,293T | Tumour | ChIP,qPCR |
| E_01_385 | | chr11:5288664~5288684 | K-562,HeLa | -- | Transient Assay,DNaseI-seq,Luciferase Reporter Assay |
| E_01_386 | | chr11:5268575~5268621 | K-562 | -- | DNase I Hypersensitivity Assay |
| E_01_387 | -- | chr11:5266021~5266708 | K-562 | -- | Transfection,RNase Protection Assay,DNase I Hypersensitivity Assay |
| E_01_388 | -- | chr16:80617~80837 | K-562 | -- | ChIP,PCR,Transfection |
| E_01_389 | -- | chr11:5248824~5249485 | Embryonic Blood Cells | -- | DNase I Hypersensitivity Assay |
| E_01_390 | | chr11:5255062~5258441 | K-562 | Erythrocytic Leukemia | Luciferase Reporter Assay,ChIP,PCR,Southern blot |
| E_01_391 | | chr3:108296550~108297750 | K-562 | -- | CAT Assay,PCR,RT-PCR |
| E_01_392 | | chr11:5250264~5250295 | K-562,HEL | Chronic myelogenous leukemia | Luciferase Reporter Assay,EMSA |
| E_01_393 | | chr11:5250535~5250560 | K-562,HEL | Chronic myelogenous leukemia | Luciferase Reporter Assay,EMSA |
| E_01_394 | | chr11:5248027~5248047 | K-562,HEL | Chronic myelogenous leukemia | Luciferase Reporter Assay,EMSA |
| E_01_395 | | chr11:5250704~5250719 | K-562,HEL | Chronic myelogenous leukemia | Luciferase Reporter Assay,EMSA |
| E_01_396 | | chr11:5250751~5250777 | K-562,HEL | Chronic myelogenous leukemia | Luciferase Reporter Assay,EMSA |
| E_01_397 | | chr11:5293686~5294250 | K-562 | -- | PCR,DNaseI-seq |
| E_01_398 | | chr11:5211019~5213983 | K-562 | -- | Luciferase Reporter Assay |
| E_01_399 | | chr11:5264845~5266345 | K-562 | -- | FISH,Transfection |
| E_01_400 | HS2 enhancer | chr11:5271421~5273421 | K-562 | -- | RNase Protection Assay |
| E_01_401 | HS2 enhancer | chr11:5286080~5288080 | K-562 | -- | DNase I Hypersensitivity Assay,RT-PCR,ChIP |
| E_01_402 | -- | chr5:110175120~110177136 | Blood | Heart Failure | Luciferase Reporter Assay,ChIP-seq |
| E_01_403 | -- | chr11:95817801~95818824 | MCF10CA1h,MCF10CA1a | Breast Cancer | ChIP,qPCR,Transfection,Western blot |
| E_01_404 | PRE | chr1:67739940~67741075 | GM12878,Th17,Th1 | Ankylosing Spondylitis | DNase I Hypersensitivity Assay |
| E_01_405 | -- | chr3:78597238~79767998 | Colorectal Cancer,Breast Cancer Cell | Colorectal Cancer,Breast Cancer | qPCR,ChIP-seq |
| E_01_406 | -- | chr9:91737604~92057238 | Primary Human BJ Fibroblasts | -- | Luciferase Reporter Assay,ChIP-qPCR,GRO-seq,ChIP-seq,4C |
| E_01_407 | -- | chr19:33299481~33300688 | Breast Cancer Cell | Colorectal Cancer | DNase I Hypersensitivity Assay,ATAC-seq,ChIP-seq |
| E_01_408 | -- | chr2:202120390~202125986 | Human Mammary Epithelial Normal Breast Cell Line | Breast Cancer | PCR,Luciferase Reporter Assay,ChIP-seq |
| E_01_409 | -- | chr12:131949637~131949801 | Normal Human Bronchial Epithelial Cells | -- | RT-qPCR,ChIP,EMSA |
| E_01_410 | -- | chr8:128310315~128312315 | Medulloblastoma Cell Lines | Medulloblastoma | qPCR,ChIP-seq,RNA-seq,4C-seq |
| E_01_411 | -- | chr2:29511793~29765640 | Medulloblastoma Cell Lines | Medulloblastoma | qPCR,ChIP-seq,RNA-seq,4C-seq |
| E_01_412 | -- | chr5:893433~1083433 | Medulloblastoma Cell Lines | Medulloblastoma | qPCR,ChIP-seq,RNA-seq,4C-seq |
| E_01_413 | -- | chr21:47716490~47892045 | Medulloblastoma Cell Lines | Medulloblastoma | qPCR,ChIP-seq,RNA-seq,4C-seq |
| E_01_414 | -- | chr2:221040922~221069549 | Medulloblastoma Cell Lines | Medulloblastoma | qPCR,ChIP-seq,RNA-seq,4C-seq |
| E_01_415 | -- | chr5:121568382~121839811 | Medulloblastoma Cell Lines | Medulloblastoma | qPCR,ChIP-seq,RNA-seq,4C-seq |
| E_01_416 | -- | chr1:230293530~230305966 | Hep G2 | -- | ChIP-seq,Luciferase Reporter Assay,EMSA |
| E_01_417 | -- | chr22:18897006~18899006 | DLBCL Cells | Diffuse Large B-Cell Lymphoma | Luciferase Reporter Assay,PCR,ChIP-seq |
| E_01_418 | -- | chr5:172196326~172199378 | MCF-7,MDA-MB-231 | Breast Cancer | ChIP-seq |
| E_01_419 | -- | chr8:29203575~29214287 | MCF-7,MDA-MB-231 | Breast Cancer | ChIP-seq |
| E_01_420 | -- | chr14:24435744~24437744 | Hep G2,HL-7702 | -- | Luciferase Reporter Assay,ChIP |
| E_01_421 | -- | chr14:61121917~61123917 | Nephron Progenitors | -- | ChIP-seq |
| E_01_422 | -- | chr14:61106417~61108417 | Nephron Progenitors | -- | ChIP-seq |
| E_01_423 | -- | chr8:140657900~141002079 | 5637 | Bladder Cancer | Luciferase Reporter Assay,ChIP,RT-PCR |
| E_01_424 | -- | chr7:95210132~95260132 | ccRCC Cells | Clear Cell Renal Cell Carcinoma | ChIP,ChIP-seq |
| E_01_425 | -- | chr1:153628434~153632039 | HEKa | Skin Barrier | RT-PCR,Western blot |
| E_02_001 | -- | chr10:52388022~52388224 | P19 | -- | Luciferase Reporter Assay |
| E_02_002 | -- | chr7:126406352~126406616 | B Cell,T Cell | -- | Luciferase Reporter Assay,ChIP |
| E_02_003 | β-cell specific Enhancer | chr3:51508734~51512187 | βTC-3,INS-1,αTC1.6,NIH3T3 | Insulin Deficiency | Luciferase Reporter Assay |
| E_02_004 | -- | chr15:97977739~97977942 | HeLa | -- | Luciferase Reporter Assay,EMSA |
| E_02_005 | -- | chr8:105528423~105529045 | N38 | -- | Transgenic mice,Luciferase Reporter Assay |
| E_02_006 | MHB Enhancer | chr4:44520195~44520234 | Lymphopoiesis B Cell | -- | Transfection,ChIP,EMSA |
| E_02_007 | CNS-2 Enhancer | chr3:37225520~37228865 | CD4+ T Cell | -- | Luciferase Reporter Assay,ChIP-qPCR,ChIP,PCR |
| E_02_008 | -- | chr6:124718594~124718929 | Hep G2,NMuLi | Diabetes Mellitus | ChIP,Luciferase Reporter Assay |
| E_02_009 | -- | chr13:53463266~53463541 | C2C12,Primary Bone Marrow–Mesenchymal Stem Cell | -- | PCR,Luciferase Reporter Assay |
| E_02_010 | -- | chr17:44494486~44495486 | C2C12,Primary Bone Marrow–Mesenchymal Stem Cell | -- | PCR,Luciferase Reporter Assay |
| E_02_011 | -- | chr17:44494598~44494816 | C2C12,Primary Bone Marrow–Mesenchymal Stem Cell | -- | PCR,Luciferase Reporter Assay |
| E_02_012 | Slc30a8 Enhancer | chr15:52315678~52316298 | Islet B-Cell | -- | Luciferase Reporter Assay,PCR |
| E_02_013 | -- | chr4:136140539~136140546 | Immortalized Murine Gonadotrope L??T2 Cell,Ovarian Cancer Cell | -- | Transfection,EMSA,Luciferase Reporter Assay,ChIP |
| E_02_014 | -- | chr3:34563695~34565695 | Axial Stem Cell | -- | EMSA,Immunostaining,Transgenic mice |
| E_02_015 | -- | chr14:67742375~67743103 | Epithelial Cell,Granulosa Cells,GT1-7,GN11,Embryonic Stem Cell | -- | RT-PCR,Luciferase Reporter Assay |
| E_02_016 | LCR | chr7:103823354~103846754 | 745A | Haploinsufficiency | ChIP,qRT-PCR,3C |
| E_02_017 | -- | chrx:7954360~7956360 | Embryonic Stem Cell | -- | Luciferase Reporter Assay,RT-PCR |
| E_02_018 | -- | chr5:115358083~115360083 | Embryonic Stem Cell | -- | Luciferase Reporter Assay,ChIP-seq |
| E_02_019 | TCCR Enhancer | chr14:78384835~78446843 | T Cell | -- | ChIP-chip,3C,ChIP,Luciferase Reporter Assay,PCR |
| E_02_020 | mRL-D5 Enhancer | chr14:78351421~78354313 | T Cell | -- | ChIP-chip,3C,ChIP,Luciferase Reporter Assay,PCR |
| E_02_021 | -- | chr14:67745496~67746000 | GT1-1 | -- | Luciferase Reporter Assay,Transfection,ChIP,qRT-PCR,EMSA |
| E_02_022 | -- | chr18:61099404~61099740 | B Cell | -- | Luciferase Reporter Assay,EMSA,ChIP |
| E_02_023 | Il12b Enhancer | chr11:44390342~44392251 | Myeloid Cells,T Cell | Autoimmune and Inflammatory Diseases | Luciferase Reporter Assay,qRT-PCR |
| E_02_024 | -- | chr5:147267614~147267639 | HIT,Hep G2,INS-1 | Diabetes Mellitus | Transfection,Luciferase Reporter Assay,EMSA,ChIP,qPCR |
| E_02_025 | -- | chr5:147267670~147267721 | HIT,Hep G2,INS-1 | Diabetes Mellitus | Transfection,Luciferase Reporter Assay,EMSA,ChIP,qPCR |
| E_02_026 | -- | chr5:147267701~147267751 | HIT,Hep G2,INS-1 | Diabetes Mellitus | Transfection,Luciferase Reporter Assay,EMSA,ChIP,qPCR |
| E_02_027 | -- | chr14:55518040~55518674 | HEK-293 | -- | Transfection,EMSA,PCR |
| E_02_028 | -- | chr7:19409838~19410044 | MM14 | -- | EMSA,Immunofluorescence,ChIP |
| E_02_029 | -- | chr15:52315678~52316298 | βTC-3,αTC-6 | Type 2 Diabetes Mellitus | Luciferase Reporter Assay,PCR |
| E_02_030 | -- | chr15:5249678~5250298 | βTC-3 | -- | Luciferase Reporter Assay |
| E_02_031 | -- | chr3:34646162~34646551 | MCF-7 | -- | Luciferase Reporter Assay |
| E_02_032 | u-PAR Enhancer | chr7:24461573~24462573 | Colon Cancer Cell | -- | RT-PCR,ChIP |
| E_02_033 | -- | chr1:38469166~38512500 | BM Cell | Acute Leukemia | Transfection,ChIP-chip,Luciferase Reporter Assay |
| E_02_034 | -- | chr11:32244715~32246895 | Primary Erythroid Cell | -- | RT-PCR,ChIP,ChIP-seq |
| E_02_035 | -- | chr11:32249976~32252156 | Primary Erythroid Cell | -- | RT-PCR,ChIP,ChIP-seq |
| E_02_036 | -- | chr11:32255189~32257369 | Primary Erythroid Cell | -- | RT-PCR,ChIP,ChIP-seq |
| E_02_037 | -- | chr11:32268128~32270308 | Primary Erythroid Cell | -- | RT-PCR,ChIP,ChIP-seq |
| E_02_038 | DHS-12 Enhancer | chr11:32264052~32266232 | Primary Erythroid Cell | -- | RT-PCR,ChIP,ChIP-seq |
| E_02_039 | -- | chr6:70763764~70765090 | S194,MPC-11 | -- | DNase I Hypersensitivity Assay,Luciferase Reporter Assay,Transfection |
| E_02_040 | Ei Enhancer | chr6:70725576~70726090 | S194,MPC-11 | -- | DNaseI-seq,Luciferase Reporter Assay,PCR |
| E_02_041 | Ed Enhancer | chr6:70743710~70744950 | S194,MPC-11 | -- | DNaseI-seq,Luciferase Reporter Assay,PCR |
| E_02_042 | E3' Enhancer | chr6:70735256~70736064 | S194,MPC-11 | -- | DNaseI-seq,Luciferase Reporter Assay,PCR |
| E_02_043 | -- | chr10:62128342~62130342 | Germ Cell | -- | ChIP,PCR,Luciferase Reporter Assay |
| E_02_044 | -- | chr4:115100426~115102426 | 416B | -- | Luciferase Reporter Assay,ChIP,EMSA |
| E_02_045 | Scl +19 Enhancer | chr4:115074426~115076426 | Hematopoietic Stem Cell,Progenitor Cell | Acute Leukemia | RT-PCR,qPCR,ChIP |
| E_02_046 | CONS3.8 Enhancer | chr14:47056226~47056692 | LS-8 Cells | -- | EMSA,Phylogenetic Footprinting |
| E_02_047 | Scn5a Enhancer | chr9:119469800~119469811 | HL-1 | Cardiac Conduction System Disease | Luciferase Reporter Assay,ChIP-seq |
| E_02_048 | Scn5a Enhancer | chr9:119469879~119469890 | HL-1 | Cardiac Conduction System Disease | Luciferase Reporter Assay,ChIP-seq |
| E_02_049 | Scn5a Enhancer | chr9:119469902~119469913 | HL-1 | Cardiac Conduction System Disease | Luciferase Reporter Assay,ChIP-seq |
| E_02_050 | -- | chr14:67741735~67744661 | GT1-7 | -- | Luciferase Reporter Assay,ChIP,PCR |
| E_02_051 | GnRH-E1 Enhancer | chr14:67743318~67743610 | GT1-7 | Polycystic Ovarian Syndrome | ChIP,PCR,Luciferase Reporter Assay,EMSA |
| E_02_052 | GnRH-E2 Enhancer | chr14:67742046~67742550 | GT1-7 | Polycystic Ovarian Syndrome | ChIP,PCR,Luciferase Reporter Assay,EMSA |
| E_02_053 | GnRH-E3 Enhancer | chr14:67740982~67741286 | GT1-7 | Polycystic Ovarian Syndrome | ChIP,PCR,Luciferase Reporter Assay,EMSA |
| E_02_054 | -- | chr1:60908875~60908895 | T Cell | -- | Luciferase Reporter Assay |
| E_02_055 | Il12b Enhancer | chr11:44390063~44390123 | HEK-293 | -- | ChIP,Luciferase Reporter Assay |
| E_02_056 | -- | chr17:26829229~26831311 | Cardiac Progenitor Cell | -- | ChIP,PCR,Luciferase Reporter Assay,EMSA |
| E_02_057 | -- | chr6:122726952~122727236 | N2a | -- | Transfection,Luciferase Reporter Assay,PCR,EMSA,ChIP |
| E_02_058 | -- | chr6:122727606~122727632 | N2a | -- | Transfection,Luciferase Reporter Assay,PCR,EMSA,ChIP |
| E_02_059 | Tal1 +40k Enhancer | chr4:115095426~115097426 | Embryonic Stem Cell | -- | ChIP,EMSA |
| E_02_060 | CE Enhancer | chr7:46352720~46353957 | C2C12 | -- | siRNA,ChIP-qPCR,qRT-PCR,ChIP-seq,DNaseI-seq |
| E_02_061 | DRR Enhancer | chr7:46370375~46374302 | C2C12 | -- | siRNA,ChIP-qPCR,qRT-PCR,ChIP-seq,DNaseI-seq |
| E_02_062 | -- | chr17:40206839~40206900 | Somatic Spleen Cells,Spermatogenic Germ Cells | -- | ChIP,qRT-PCR |
| E_02_063 | -- | chr5:107680655~107682655 | Hematopoietic Cell,B Cell,T Cell | -- | ChIP,PCR,Luciferase Reporter Assay |
| E_02_064 | ECR18 Enhancer | chr7:6502892~6504892 | HeLa,HEK-293 | -- | ChIP-seq,3C,Luciferase Reporter Assay,PCR,ChIP |
| E_02_065 | -- | chr5:28476034~28479024 | Colon Adenocarcinoma Cell Lines | -- | RT-PCR,ChIP-seq,Transient Transfection Assay,Luciferase Reporter Assay,3C,DNaseI-seq |
| E_02_066 | -- | chr5:28495262~28497421 | Colon Adenocarcinoma Cell Lines | -- | RT-PCR,ChIP-seq,Transient Transfection Assay,Luciferase Reporter Assay,3C,DNaseI-seq |
| E_02_067 | -- | chr5:28500370~28502363 | Colon Adenocarcinoma Cell Lines | -- | RT-PCR,ChIP-seq,Transient Transfection Assay,Luciferase Reporter Assay,3C,DNaseI-seq |
| E_02_068 | -- | chr5:28561915~28564905 | Colon Adenocarcinoma Cell Lines | -- | RT-PCR,ChIP-seq,Transient Transfection Assay,Luciferase Reporter Assay,3C,DNaseI-seq |
| E_02_069 | ECR9 Enhancer | chr19:10215891~10216703 | Oligodendroglial Cell | -- | ChIP,Luciferase Reporter Assay,EMSA,qPCR |
| E_02_070 | -- | chr2:119321593~119322529 | 293T,Progenitor Cell | -- | ChIP,PCR,EMSA |
| E_02_071 | -- | chr2:119321593~119322529 | 293T,Progenitor Cell | -- | ChIP,PCR,EMSA |
| E_02_072 | -- | chr11:111838889~111839334 | Cartilage | -- | ChIP-qPCR |
| E_02_073 | -- | chr16:59471850~59472124 | EL4 | Pulmonary Inflammation | ChIP,Luciferase Reporter Assay |
| E_02_074 | -- | chr6:115409226~115436116 | Embryonic Stem Cell | -- | ChIP-seq,qPCR,RNA-seq |
| E_02_075 | -- | chr6:115507545~115533315 | Embryonic Stem Cell | -- | ChIP-seq,PCR,RNA-seq |
| E_02_076 | -- | chr2:115794340~115800495 | Embryonic Stem Cell | -- | ChIP-qPCR,ChIP-seq,ChIP,3C |
| E_02_077 | -- | chr6:52296135~52334522 | Limb Cells | -- | ChIP,PCR,3C,5C,ChIP-seq |
| E_02_078 | -- | chr6:52585919~52613016 | Limb Cells | -- | ChIP,PCR,3C,5C,ChIP-seq |
| E_02_079 | -- | chr6:52765812~52891511 | Limb Cells | -- | ChIP,PCR,3C,5C,ChIP-seq |
| E_02_080 | -- | chr6:52908070~53037532 | Limb Cells | -- | ChIP,PCR,3C,5C,ChIP-seq |
| E_02_081 | -- | chr4:147962887~147964479 | 293T | Heart Failure | RT-PCR,3C,ChIP,Luciferase Reporter Assay |
| E_02_082 | -- | chr7:100474191~100474841 | Platinum E cells | -- | Luciferase Reporter Assay,PCR,EMSA,ChIP-seq |
| E_02_083 | -- | chr17:44464986~44466986 | Osteoblast-Specific Cell | -- | Luciferase Reporter Assay,ChIP,EMSA |
| E_02_084 | -- | chr6:52199038~52200503 | Lung,Stomach | -- | EMSA,ChIP |
| E_02_085 | -- | chr1:133347808~133348049 | Kidney | -- | RT-PCR,Southern blot |
| E_02_086 | -- | chr16:23143036~23145036 | Offspring Adipocytes | Sleep Fragmentation | ChIP,qRT-PCR,Western blot |
| E_02_087 | -- | chr4:124638991~124641160 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_088 | -- | chr4:124645999~124647927 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_089 | -- | chr5:119677099~119681977 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_090 | -- | chr5:119704124~119707831 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_091 | -- | chr5:119707931~119710758 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_092 | -- | chr5:119710660~119714758 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_093 | -- | chr5:98290964~98295647 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_094 | -- | chr5:98307793~98312281 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_095 | -- | chr5:98310330~98314427 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_096 | -- | chr5:98253530~98257713 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_097 | -- | chr2:25423079~25423874 | Th1 | -- | ChIP |
| E_02_098 | -- | chr17:31172998~31173656 | COS-1 | -- | 3C,ChIP,RNA-seq,GRO-seq,Luciferase Reporter Assay |
| E_02_099 | -- | chr17:45890060~45890829 | COS-1 | -- | 3C,ChIP,RNA-seq,GRO-seq,Luciferase Reporter Assay |
| E_02_100 | -- | chrx:140806807~140808327 | F9 | -- | Luciferase Reporter Assay,ChIP |
| E_02_101 | -- | chr2:91067374~91069374 | Bone Marrow Cell,Leukemic Stem Cell,Hematopoietic Stem Cell,416B | Leukemia | ChIP,3C,Transgenic mice |
| E_02_102 | -- | chr17:35502632~35504632 | Embryonic Stem Cell | -- | Luciferase Reporter Assay,ChIP,ChIP-qPCR |
| E_02_103 | -- | chr6:122700483~122702483 | Embryonic Stem Cell | -- | Luciferase Reporter Assay,ChIP,ChIP-qPCR |
| E_02_104 | -- | chr9:99131669~99132862 | Ventricular Cardiomyocytes (NRVMs) | Heart Injuries | Luciferase Reporter Assay,ChIP-seq |
| E_02_105 | -- | chr1:182851627~182852853 | Tet2-/- | -- | ChIP-seq,ChIP |
| E_02_106 | -- | chr1:182852133~182854320 | Tet2-/- | -- | ChIP-seq,ChIP |
| E_02_107 | | chr1:182856227~182857187 | Tet2-/- | -- | ChIP-seq,ChIP |
| E_02_108 | -- | chr11:35178343~35180368 | Tet2-/- | -- | ChIP-seq,ChIP |
| E_02_109 | -- | chr11:35813868~35814943 | Tet2-/- | -- | ChIP-seq,ChIP |
| E_02_110 | -- | chr11:102006458~102008458 | Osteocyte Cell Lines | -- | Luciferase Reporter Assay,ChIP |
| E_02_111 | -- | chr10:34385685~34385834 | MCT Cells | Skeletal Diseases | Transgenic mice,ChIP,qRT-PCR,EMSA |
| E_02_112 | -- | chr15:63254341~63256341 | T-acute lymphoblastic leukemia (T-ALL) | Acute Lymphoblastic Leukemia | ChIP-seq,EMSA,3C |
| E_02_113 | -- | chr7:53527011~53528648 | C2C12 | -- | ChIP,PCR |
| E_02_114 | -- | chr2:167687771~167689503 | Monocytes | -- | ChIP-seq,ATAC-seq |
| E_02_115 | -- | chr4:66837166~66852551 | Dendritic Cells | -- | ChIP-seq,ATAC-seq |
| E_02_116 | -- | chr8:120737580~120746913 | Monocytes | -- | ChIP-seq,ATAC-seq |
| E_02_117 | ARC-specific Enhancer | chr1:133303739~133325138 | Kisspeptin-Immunoreactive Cell | -- | DNase-seq,Immunofluorescence,Luciferase Reporter Assay,PCR,3C |
| E_02_118 | -- | chr3:34743178~34776096 | Embryonic Stem Cell | -- | ChIP-seq,RNA-seq |
| E_02_119 | -- | chr11:98979280~98979880 | COS-7 | -- | Luciferase Reporter Assay,ChIP |
| E_02_120 | Cx30.2 Enhancer | chr14:63196014~63196614 | Cx30.2+ Cells | -- | Luciferase Reporter Assay,ChIP |
| E_02_121 | ECR2 Enhancer | chr4:136148484~136149239 | Hep G2 | -- | Luciferase Reporter Assay |
| E_02_122 | ECR1 Enhancer | chr4:136140654~136141162 | Hep G2 | -- | Luciferase Reporter Assay |
| E_02_123 | E8VI Enhancer | chr6:71341692~71345212 | CD4+ T Cell | -- | ChIP,PCR |
| E_02_124 | -- | chr10:62893206~62923461 | Embryonic Stem Cell | -- | ChIP-seq,Luciferase Reporter Assay |
| E_02_125 | -- | chr3:133531418~133563926 | Embryonic Stem Cell | -- | ChIP-seq,Luciferase Reporter Assay |
| E_02_126 | -- | chr12:3944001~3947078 | AtT-20,Pituitary Corticotrope Cell | -- | ChIP-seq,3C,ChIP |
| E_02_127 | -- | chr12:3956137~3961266 | AtT-20,Pituitary Corticotrope Cell | -- | ChIP-seq,3C,ChIP |
| E_02_128 | -- | chr12:3938522~3942093 | Pituitary Corticotrope Cell | -- | ChIP-seq,3C,ChIP |
| E_02_129 | Ucp1 Enhancer | chr8:83287848~83288068 | Brown Fat Cell | -- | ChIP,RT-PCR |
| E_02_130 | MyoD distal Enhancer | chr7:46351197~46355693 | C2C12 | -- | Luciferase Reporter Assay,ChIP |
| E_02_131 | Grhl3 Enhancer | chr4:135548688~135550688 | NMuMG | -- | Luciferase Reporter Assay,3C |
| E_02_132 | -- | chr8:106613868~106615868 | NMuMG | -- | Luciferase Reporter Assay,3C |
| E_02_133 | -- | chr8:109134068~109136068 | NMuMG | -- | Luciferase Reporter Assay,3C |
| E_02_134 | -- | chr8:106610150~106612150 | Non-tumorigenic Mouse Mammary Gland Cells | -- | Luciferase Reporter Assay,3C |
| E_02_135 | -- | chr17:35499359~35507923 | Mouse Embryonic Stem Cell | -- | CRISPR/Cas9,3C,Luciferase Reporter Assay,ATAC-seq |
| E_02_136 | -- | chr5:119654061~119663588 | Mouse Embryonic Stem Cell | -- | CRISPR/Cas9,3C,Luciferase Reporter Assay,ATAC-seq |
| E_02_137 | -- | chr1:13041306~13127367 | Embryonic Stem Cell | -- | Luciferase Reporter Assay |
| E_02_138 | -- | chr17:31794375~31829875 | Embryonic Stem Cell | -- | Luciferase Reporter Assay |
| E_02_139 | -- | chr17:35501272~35506872 | Embryonic Stem Cell | -- | Luciferase Reporter Assay |
| E_02_140 | -- | chr7:3183157~3229407 | Embryonic Stem Cell | -- | Luciferase Reporter Assay |
| E_02_141 | -- | chr3:127641624~127642545 | Embryonic Stem Cell | -- | ChIP-qPCR,ChIP-seq,RNA-seq |
| E_02_142 | -- | chr4:34888479~34889907 | αT3-1 Cells | -- | qPCR,ChIP,3C |
| E_02_143 | Ccnb1ip1 Enhancer | chr14:50787449~50787634 | Mitotic Cell | -- | Luciferase Reporter Assay,ChIP,RT-PCR |
| E_02_144 | Id2 Enhancer | chr12:25090158~25090663 | HCT 116,SW480 | Colorectal Carcinoma | Luciferase Reporter Assay,ChIP-PCR,ChIP |
| E_02_145 | -- | chr8:84899088~84902859 | Murine erythroleukemia (MEL) line 745A,32DEpo1,293T | -- | ChIP |
| E_02_146 | AHF Enhancer | chr13:83661050~83662862 | Embryonic Stem Cell | Heart Failure | 3C-qPCR,3C-seq |
| E_02_147 | OFTRV Enhancer | chr8:59795280~59797080 | Embryonic Stem Cell | Heart Failure | 3C-qPCR |
| E_02_148 | CNS1 Enhancer | chr10:78046488~78046636 | Thymic Medullary Epithelial Cells (mTECs) | -- | qPCR |
| E_02_149 | CD47 Enhancer | chr16:49740654~49742654 | G1E Cells | -- | RT-qPCR,ChIP |
| E_02_150 | Nodal proximal epiblast Enhancer (PEE) | chr10:61403948~61408233 | Embryonic Stem Cell | -- | ChIP,ChIP-seq |
| E_02_151 | Nodal Enhancer (NDE) | chr10:61402781~61405448 | Embryonic Stem Cell | -- | ChIP,ChIP-seq |
| E_02_152 | EphA7 Enhancer | chr4:29115647~29140947 | Embryo | -- | PCR,Transgenic mice |
| E_02_153 | EphA7 Enhancer | chr4:29119847~29120047 | Embryo | -- | PCR,Transgenic mice |
| E_02_154 | -- | chr4:55565908~55608014 | Mouse Embryonic Stem Cell | -- | ChIP-seq,ChIP |
| E_02_155 | -- | chr6:122653828~122675804 | Mouse Embryonic Stem Cell | -- | ChIP-seq,ChIP |
| E_02_156 | -- | chr6:122696853~122708211 | Mouse Embryonic Stem Cell | -- | ChIP-seq,ChIP |
| E_02_157 | -- | chr12:85433906~85439068 | Mouse Cortical Neurons | -- | ChIP-seq,Luciferase Reporter Assay |
| E_02_158 | -- | chr12:85452549~85458571 | Mouse Cortical Neurons | -- | ChIP-seq,Luciferase Reporter Assay |
| E_02_159 | -- | chr12:85466416~85469570 | Mouse Cortical Neurons | -- | ChIP-seq,Luciferase Reporter Assay |
| E_02_160 | -- | chr12:85470646~85474086 | Mouse Cortical Neurons | -- | ChIP-seq,Luciferase Reporter Assay |
| E_02_161 | -- | chr12:85482048~85490068 | Mouse Cortical Neurons | -- | ChIP-seq,Luciferase Reporter Assay |
| E_02_162 | -- | chr2:168744572~168752225 | Induced Pluripotent Stem Cells | -- | ChIP-seq,ATAC-seq,CRISPR/Cas9 |
| E_02_163 | -- | chr8:89041889~89090124 | Induced Pluripotent Stem Cells | -- | ChIP-seq,ATAC-seq,CRISPR/Cas9 |
| E_02_164 | -- | chr12:85515101~85543901 | Macrophage | -- | ChIP-seq |
| E_02_165 | TRA Enhancer | chr14:54227135~54228033 | P5424 | -- | ChIP-seq,ChIP |
| E_02_166 | E8II Enhancer | chr6:71321750~71323696 | P5424 | -- | ChIP-seq,ChIP |
| E_02_167 | -- | chr2:172513228~172520500 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RT-qPCR |
| E_02_168 | -- | chr2:172541319~172544955 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RT-qPCR |
| E_02_169 | -- | chr2:172574046~172577682 | Mouse Embryonic Stem Cell | -- | ChIP-seq,RT-qPCR |
| E_02_170 | -- | chr14:69196226~69202226 | G1ER Erythroid Cell | -- | CRISPR/Cas9,ChIP-seq |
| E_02_171 | -- | chr14:119710660~119714758 | G1ER Erythroid Cell | -- | CRISPR/Cas9,ChIP-seq |
| E_02_172 | -- | chr14:69221635~69222851 | G1ER Erythroid Cell | -- | CRISPR/Cas9,ChIP-seq |
| E_02_173 | Tce1 Enhancer | chr2:10136078~10138078 | T Cell | -- | CRISPR/Cas9,ChIP,RT-PCR |
| E_02_174 | -- | chr7:35156353~35161233 | Myeloid Cells | -- | ChIP-seq,CRISPR/Cas9,Transgenic mice |
| E_02_175 | -- | chr7:129554284~129564284 | Rat Chondrosarcoma Cells (RCS cells) | Skeletal Diseases | Luciferase Reporter Assay,ChIP-seq |
| E_02_176 | -- | chr9:78368337~78376479 | Embryonic Stem Cell | -- | Luciferase Reporter Assay,RT-qPCR,ChIP-seq |
| E_02_177 | -- | chr5:137465620~137479420 | Renal EPO-producing (REP) Cells | Renal Anemia | Luciferase Reporter Assay,Transgenic mice |
| E_02_178 | -- | chr15:63833002~63863200 | HCT 116 | Colon Cancer | ChIP-seq |
| E_02_179 | -- | chr15:63865799~63896492 | HCT 116 | Colon Cancer | ChIP-seq |
| E_02_180 | -- | chr15:63894512~63932136 | HCT 116 | Colon Cancer | ChIP-seq |
| E_02_181 | -- | chr18:69656860~69683465 | HoxB8-FL cells | -- | ATAC-seq |
| E_02_182 | TES/TESCO Enhancer | chr11:112769210~112772210 | Testis | -- | Transgenic mice,CRISPR/Cas9,qRT-PCR |
| E_02_183 | Id2 Enhancer | chr12:25090158~25096935 | Apoptotic Cell | Colorectal Carcinoma | Luciferase Reporter Assay |
| E_02_184 | -- | chr2:105072843~105076843 | Sertoli Cells | Genitourinary Defects | ChIP-seq,DNaseI-seq |
| E_02_185 | -- | chr15:97898854~97902854 | YAMC Cell | Colon Cancer | Luciferase Reporter Assay,Western blot,DNaseI-seq |
| E_02_186 | -- | chr15:97911426~97915997 | YAMC Cell | Colon Cancer | Luciferase Reporter Assay,Western blot,DNaseI-seq |
| E_02_187 | -- | chr6:88202011~88204330 | Embryonic Endothelial Cell | -- | Luciferase Reporter Assay,ChIP-seq,Western blot |
| E_02_188 | -- | chr11:44386118~44393090 | Macrophage | Inflammatory Disease | ChIP-seq |
| E_02_189 | -- | chr4:97123309~97712957 | Embryonic Fibroblast | Malignancies | ChIP-seq |
| E_02_190 | -- | chr5:9034150~9036900 | Liver | -- | ChIP-seq |
| E_02_191 | -- | chr5:9037806~9041881 | Liver | -- | ChIP-seq |
| E_02_192 | -- | chr5:9038118~9038593 | Liver | -- | ChIP-seq |
| E_02_193 | -- | chr1:136170878~136192613 | C2C12 | -- | ChIP-seq |
| E_02_194 | ephrin-A5 Enhancer | chr17:62627957~62633457 | Mesencephalon | -- | Luciferase Reporter Assay |
| E_02_195 | -- | chr9:88325101~88326201 | Hepatic Myofibroblasts | Hepatic Fibrosis | Luciferase Reporter Assay |
| E_02_196 | -- | chr8:36785613~36985613 | Brain | Schizophrenia | ChIP-seq,Hi-C |
| E_02_197 | -- | chr10:67853705~67855705 | Embryo | -- | ChIP-seq,4C-seq |
| E_02_198 | -- | chr10:67926705~67928705 | Embryo | -- | ChIP-seq,4C-seq |
| E_02_199 | Col1a2 Enhancer | chr6:4438697~4440197 | Mesenchymal-Fibroblast Cells | Fibrotic Disease | Luciferase Reporter Assay,DNase I Hypersensitivity Assay,ChIP-seq |
| E_02_200 | -- | chr4:55449628~55461828 | Mouse Embryonic Stem Cell | -- | Luciferase Reporter Assay,3C |
| E_02_201 | -- | chr4:55453628~55465828 | Mouse Embryonic Stem Cell | -- | Luciferase Reporter Assay,3C |
| E_02_202 | -- | chr16:92625802~92627802 | HPC-7 | Leukaemia | 4C-seq,ChIP |
| E_02_203 | Il2ra Enhancer | chr8:11564419~11614821 | T Cell | -- | ChIP-seq,ChIA-PET |
| E_02_204 | -- | chr14:18175266~18186392 | Hepatocellular Carcinoma | Hepatocellular Carcinoma | ChIP-seq |
| E_02_205 | -- | chr2:122651534~122668846 | Macrophage | -- | 3C-seq,ChIP-seq |
| E_02_206 | -- | chr2:103887795~103888195 | Embryo | -- | ChIP-seq |
| E_02_207 | -- | chr2:103886995~103888995 | Embryo | -- | ChIP-seq |
| E_02_208 | -- | chr1:131878852~131942815 | Liver,Kidney | -- | 4C-seq,Transgenic mice,RNA-seq |
| E_02_209 | -- | chr1:131920349~131962471 | Liver,Kidney | -- | 4C-seq,Transgenic mice,RNA-seq |
| E_02_210 | -- | chr10:24357349~24375452 | Embryonic Limb | -- | Transgenic mice,ChIP-seq,DNase I Hypersensitivity Assay |
| E_02_211 | -- | chr10:24386336~24406594 | Embryonic Limb | -- | Transgenic mice,ChIP-seq,DNase I Hypersensitivity Assay |
| E_02_212 | -- | chr10:24449590~24469418 | Embryonic Limb | -- | Transgenic mice,ChIP-seq,DNase I Hypersensitivity Assay |
| E_02_213 | -- | chr10:24483642~24503469 | Embryonic Limb | -- | Transgenic mice,ChIP-seq,DNase I Hypersensitivity Assay |
| E_02_214 | -- | chr10:21410566~21412861 | Primary Mouse Embryonic Fibroblasts | -- | ChIP-seq,ATAC-seq |
| E_02_215 | -- | chr11:19833945~19851027 | Primary Mouse Embryonic Fibroblasts | -- | ChIP-seq,ATAC-seq |
| E_02_216 | -- | chr17:45790442~45800636 | Primary Mouse Embryonic Fibroblasts | -- | ChIP-seq,ATAC-seq |
| E_02_217 | -- | chr10:50623698~50625698 | Hypothalamus | Haploinsufficiency | ChIP-seq,ATAC-seq |
| E_02_218 | -- | chr2:75120051~75165771 | Murine Limb Bud Cells | -- | Hi-C,4C,ChIP-seq |
| E_02_219 | -- | chr2:75413472~75451553 | Murine Limb Bud Cells | -- | Hi-C,4C,ChIP-seq |
| E_02_220 | -- | chr2:126601468~126603468 | Connective Tissue Mast Cell | IgE/mast cell-mediated anaphylaxis | ChIP-seq,Luciferase Reporter Assay |
| E_02_221 | -- | chr2:126593905~126595430 | Connective Tissue Mast Cell | IgE/mast cell-mediated anaphylaxis | ChIP-seq,Luciferase Reporter Assay |
| E_02_222 | -- | chr7:143459172~143459787 | Mouse Embryonic Fibroblasts | Malignancies | Luciferase Reporter Assay |
| E_02_223 | -- | chr7:143462624~143463585 | Mouse Embryonic Fibroblasts | Malignancies | Luciferase Reporter Assay |
| E_02_224 | -- | chr15:63714919~63952099 | Bone Marrow | Leukaemia | ChIP-seq |
| E_02_225 | MdE Enhancer | chr1:133347574~133364574 | As4.1,Tsukuba hypertensive mice | Hypertension | Luciferase Reporter Assay,ChIP |
| E_02_226 | -- | chr19:61151074~61161722 | Monocytes,Dendritic Cells | -- | ChIP-seq |
| E_02_227 | -- | chr19:61158643~61164569 | Monocytes,Dendritic Cells | -- | ChIP-seq |
| E_02_228 | -- | chr19:61165425~61172555 | Monocytes,Dendritic Cells | -- | ChIP-seq |
| E_02_229 | -- | chr2:144000110~144014615 | Monocytes,Dendritic Cells | -- | ChIP-seq |
| E_02_230 | -- | chr2:144014506~144023297 | Monocytes,Dendritic Cells | -- | ChIP-seq |
| E_02_231 | -- | chr2:103464661~103471206 | Monocytes,Dendritic Cells | -- | ChIP-seq |
| E_02_232 | -- | chr6:127033997~127036097 | Osteocyte Cell Lines | Chronic Kidney Disease | ChIP-seq,CRISPR/Cas9 |
| E_02_233 | -- | chr11:112217210~112217767 | Testis | -- | DNaseI-seq,ChIP-seq |
| E_02_234 | -- | chr17:85527960~85530660 | The Subventricular Zone Of Lateral Ganglionic Eminence??LGE SVZ?? | -- | Luciferase Reporter Assay,ChIP-seq |
| E_02_235 | -- | chr17:85463916~85466386 | The Subventricular Zone Of Lateral Ganglionic Eminence??LGE SVZ?? | -- | Luciferase Reporter Assay,ChIP-seq |
| E_02_236 | -- | chr17:85392908~85395234 | The Subventricular Zone Of Lateral Ganglionic Eminence??LGE SVZ?? | -- | Luciferase Reporter Assay,ChIP-seq |
| E_02_237 | DRR Enhancer | chr7:46371356~46373481 | C2C12 | -- | ChIRP |
| E_02_238 | -- | chr13:56243248~56243833 | P19 | -- | ChIP |
| E_02_239 | -- | chr13:56244114~56244357 | P19 | -- | ChIP |
| E_02_240 | -- | chr13:56245174~56245857 | P19 | -- | ChIP |
| E_02_241 | -- | chr13:30108722~30109111 | Embryonic Stem Cell,Epiblast-like Cells (EpiLCs) | -- | ChIP-seq |
| E_02_242 | -- | chr13:30123333~30124861 | Embryonic Stem Cell,Epiblast-like Cells (EpiLCs) | -- | ChIP-seq |
| E_02_243 | -- | chr13:30144166~30145833 | Embryonic Stem Cell | -- | ChIP-seq |
| E_02_244 | -- | chr8:106608533~106609800 | Embryonic Stem Cell | -- | ChIP-seq |
| E_02_245 | -- | chr8:106610533~106611666 | Embryonic Stem Cell | -- | ChIP-seq |
| E_02_246 | -- | chr11:6639091~6639657 | Mammary | -- | ChIP-seq |
| E_02_247 | -- | chr11:6639824~6640424 | Mammary | -- | ChIP-seq |
| E_02_248 | -- | chr11:6644257~6644824 | Mammary | -- | ChIP-seq |
| E_02_249 | -- | chr11:6639029~6644397 | Mammary | -- | ChIP-seq |
| E_02_250 | Gata3 distal Enhancers | chr2:9838078~9840078 | Mouse Embryos | -- | Luciferase Reporter Assay,qPCR |
| E_02_251 | Ciita Enhancer | chr16:10440279~10442279 | Macrophage | -- | qChIP |
| E_02_252 | STAT5 Enhancers | chr11:100854851~100856851 | Mammary | -- | ChIP-seq,CRISPR/Cas9 |
| E_02_253 | Eμ Enhancer | chr12:114640000~114670000 | B Cell | Autoimmune Diseases | ChIP |
| E_02_254 | -- | chr12:114460000~114490000 | B Cell | Autoimmune Diseases | ChIP |
| E_02_255 | -- | chr17:85795937~85796217 | Metanephric Mesenchymal (MM) cells | -- | ChIP-seq |
| E_02_256 | -- | chr17:85797325~85797927 | Metanephric Mesenchymal (MM) cells | -- | ChIP-seq |
| E_02_257 | BdR Enhancer | chr17:30249928~30278499 | Mouse Embryonic Stem Cell | -- | ChIP-seq,ChIA-PET |
| E_02_258 | BdR Enhancer | chr6:98336842~98365566 | Mouse Embryonic Stem Cell | -- | ChIP-seq,ChIA-PET |
| E_02_259 | -- | chr12:35939690~35990427 | ST2 | -- | ChIP-seq |
| E_02_260 | -- | chr12:35841201~35921783 | ST2 | -- | ChIP-seq |
| E_02_261 | -- | chr12:35769572~35823293 | ST2 | -- | ChIP-seq |
| E_02_262 | -- | chr12:35690979~35768472 | ST2 | -- | ChIP-seq |
| E_02_263 | -- | chr5:147205131~147212149 | Pancreas | Pancreatic Hypoplasia | ChIP,ChIP-seq |
| E_02_264 | -- | chr5:147263601~147264086 | Pancreas | Pancreatic Hypoplasia | ChIP,ChIP-seq |
| E_02_265 | Enhancer N2 | chr3:34645597~34646134 | Mouse Embryos | -- | ChIP |
| E_02_266 | -- | chr14:67745323~67746327 | GT1-1 | -- | Luciferase Reporter Assay,ChIP |
| E_02_267 | -- | chr17:35501113~35507015 | Embryonic Stem Cell | -- | Luciferase Reporter Assay,ChIP-seq |
| E_02_268 | -- | chr6:52407532~52459468 | Limb,Head | Limb malformation | ChIP-seq,3C,5C |
| E_02_269 | -- | chr6:52527210~52556565 | Limb,Head | Limb malformation | ChIP-seq,3C,5C |
| E_02_270 | miR-290-295 SE | chr7:3193003~3218182 | Embryonic Stem Cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_271 | miR-290-295 SE (E1) | chr7:3199567~3201439 | Embryonic Stem Cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_272 | miR-290-295 SE (E2) | chr7:3202646~3204360 | Embryonic Stem Cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_273 | miR-290-295 SE (E3) | chr7:3205726~3207280 | Embryonic Stem Cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_274 | miR-290-295 SE (E4) | chr7:3209567~3211439 | Embryonic Stem Cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_275 | miR-290-295 SE (E6) | chr7:3212448~3214558 | Embryonic Stem Cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_276 | miR-290-295 SE (E7) | chr7:3216607~3218399 | Embryonic Stem Cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_277 | miR-1 SE | chr2:180362582~180377003 | myotubes | -- | CRISPR/Cas9,RT-qPCR |
| E_02_278 | miR-1 SE(M1) | chr2:180361998~180364335 | myotubes | -- | CRISPR/Cas9,RT-qPCR |
| E_02_279 | miR-1 SE(M2) | chr2:180366734~180368371 | myotubes | -- | CRISPR/Cas9,RT-qPCR |
| E_02_280 | miR-1 SE(M3) | chr2:180367903~180369540 | myotubes | -- | CRISPR/Cas9,RT-qPCR |
| E_02_281 | miR-1 SE(M4) | chr2:180375974~180377844 | myotubes | -- | CRISPR/Cas9,RT-qPCR |
| E_02_282 | miR-148a SE1 | chr6:51108708~51130031 | Pro-B cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_283 | miR-148a SE2 | chr6:51168034~51174811 | Pro-B cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_284 | miR-148a SE(B1) | chr6:51117747~51120656 | Pro-B cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_285 | miR-148a SE(B3) | chr6:51168147~51170512 | Pro-B cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_286 | miR-148a SE(B4) | chr6:51171474~51173111 | Pro-B cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_287 | miR-148a SE(B5) | chr6:51173363~51175544 | Pro-B cell | -- | CRISPR/Cas9,RT-qPCR |
| E_02_288 | | chr2:129350852~129356319 | Macrophage | -- | ChIP-qPCR,ChIP-seq |
| E_02_289 | | chr12:109528035~109532509 | Embryonic Stem Cell | -- | ChIP-seq,ChIP |
| E_02_290 | -- | chr12:103852772~103852898 | Hepatoma Cells | -- | Transient Assay,EMSA |
| E_02_291 | | chr12:103852898~103853032 | Hepatoma Cells | -- | Transient Assay,EMSA |
| E_02_292 | | chr12:103853032~103853127 | Hepatoma Cells | -- | Transient Assay,EMSA |
| E_02_293 | | chr7:103771431~103772043 | Pleen Cells,MEL cells | -- | PCR,DNaseI-seq |
| E_02_294 | Ei | chr6:67556736~67558736 | B Cell,T Cell,MPC-11 | -- | 3C,PCR |
| E_02_295 | E3' | chr6:67561736~67563736 | B Cell,T Cell,MPC-11 | -- | 3C,PCR |
| E_02_296 | Ed | chr6:67560136~67562136 | B Cell,T Cell,MPC-11 | -- | 3C,PCR |
| E_02_297 | -- | chr8:120876144~120876856 | Mouse Embryos | -- | 3C,ChIP-seq |
| E_02_298 | -- | chr8:120882734~120883410 | Mouse Embryos | -- | 3C,ChIP-seq |
| E_02_299 | -- | chr8:121088830~121089174 | Mouse Embryos | -- | 3C,ChIP-seq |
| E_02_300 | -- | chr17:63168191~63175262 | Embryonic Stem Cell | -- | Luciferase Reporter Assay,PCR,ChIP-seq |
| E_02_301 | -- | chr10:87283358~87312833 | Embryonic Stem Cell | -- | Luciferase Reporter Assay,PCR,ChIP-seq |
| E_02_302 | MCE | chr17:26829232~26829742 | Cardiac Progenitor Cell | -- | Luciferase Reporter Assay,Transient Transfection Assay |
| E_02_303 | -- | chr2:152735054~152735521 | Embryonic Stem Cell | -- | qRT-PCR,ChIP |
| E_02_304 | -- | chr13:43362622~43364444 | C2C12,MEFs | -- | ChIP-qPCR,ChIP-seq,ChIP,EMSA,Luciferase Reporter Assay,qPCR |
| E_02_305 | -- | chr2:130280565~130281887 | C2C12,MEFs | -- | ChIP-qPCR,ChIP-seq,ChIP,EMSA,Luciferase Reporter Assay,qPCR |
| E_02_306 | -- | chr16:4721118~4724819 | C2C12,MEFs | -- | ChIP-qPCR,ChIP-seq,ChIP,EMSA,Luciferase Reporter Assay,qPCR |
| E_02_307 | -- | chr10:77989870~77993100 | C2C12,MEFs | -- | ChIP-qPCR,ChIP-seq,ChIP,EMSA,Luciferase Reporter Assay,qPCR |
| E_02_308 | -- | chr4:115040426~115042426 | HPC-7 | Malignant Hematopoiesis | DNaseI-seq,ChIP,ChIP-seq,Hi-C,Transgenic mice |
| E_02_309 | -- | chr12:113302447~113305102 | Blood | -- | PCR,ChIP |
| E_02_310 | -- | chr12:113305522~113308796 | Blood | -- | PCR,ChIP |
| E_02_311 | -- | chr12:113314217~113314925 | Blood | -- | PCR,ChIP |
| E_02_312 | -- | chr11:100859351~100885169 | Mammary Epithelium | -- | PCR,ChIP-seq,RT-PCR,DNase-seq |